The Peter Attia Drive - November 26, 2018


#30 - Thomas Seyfried, Ph.D.: Controversial discussion—cancer as a mitochondrial metabolic disease?


Episode Stats

Length

2 hours and 48 minutes

Words per Minute

193.14105

Word Count

32,503

Sentence Count

2,231

Misogynist Sentences

12

Hate Speech Sentences

13


Summary

In this episode, Dr. Tom Seifffried joins me to talk about his background in genetics and biochemistry, his interest in ketones and ketosis, and the Warburg Effect. We also talk about the idea of substrate specificity and the role it plays in understanding ketosis.


Transcript

00:00:00.000 Hey everyone, welcome to the Peter Atiyah Drive. I'm your host, Peter Atiyah.
00:00:10.140 The drive is a result of my hunger for optimizing performance, health, longevity, critical thinking,
00:00:15.600 along with a few other obsessions along the way. I've spent the last several years working with
00:00:19.840 some of the most successful top performing individuals in the world. And this podcast
00:00:23.620 is my attempt to synthesize what I've learned along the way to help you live a higher quality,
00:00:28.360 more fulfilling life. If you enjoy this podcast, you can find more information on today's episode
00:00:33.020 and other topics at peteratiyahmd.com.
00:00:41.420 Hello, everyone. Welcome to this week's episode of the Peter Atiyah Drive. My guest this week is
00:00:47.540 Professor Tom Seyfried, who many of you will know, but I suspect an equal number of you will not know.
00:00:53.020 Tom has come to us through many channels, meaning the requests to speak with Tom have come on many
00:01:00.720 levels. There's been a lot of requests through social media, through the site. And of course,
00:01:06.680 based on our discussions with Dom D'Agostino, Tom has been front of mind for quite a while.
00:01:12.120 This is my first time meeting Tom, but I feel sort of like I know him because I've read so much of his
00:01:18.460 work. And Bob Kaplan, who, of course, you all know as my trusty right-hand guy who lives in Boston,
00:01:25.560 actually takes a course from Tom. And he's taken a course in the past and continues to
00:01:30.960 just wander around Tom's office and just hang out with him overall. So in some ways,
00:01:35.980 this felt kind of familiar, though it was my first time meeting Tom. Tom's background is that he's got
00:01:40.160 a PhD in genetics and biochemistry from the University of Illinois. Got that in the mid-70s and a bunch of
00:01:44.960 other distinctions that I'm not going to go into because we're going to link to all that stuff. He did
00:01:48.880 his postdoc in the Department of Neurology at Yale, and it was there that he first became interested
00:01:54.400 in ketones because of their application in the amelioration of recalcitrant seizures. As we get into
00:02:02.920 in the episode, that led to his interest in cancer, which is now his focus. Tom has published over 150
00:02:10.560 peer-reviewed publications. He's the author of numerous books, textbooks, etc., including kind
00:02:17.180 of a treatise on this. So his magnum opus is effectively a book called Cancer as a Metabolic
00:02:24.060 Disease. I probably got my first copy of this a few years ago, and in many ways, that's what sort of
00:02:29.520 felt quite familiar in speaking with him. He's currently a professor at Boston College, and his research
00:02:35.380 today focuses on the mechanisms by which metabolic therapies can manage chronic diseases such as
00:02:40.160 epilepsy, neurodegenerative lipid storage diseases, and above all, cancer. In this episode, we talk
00:02:46.860 about Tom's background, as I sort of alluded to, his work in epilepsy and how that led him to the
00:02:51.500 interest in caloric restriction and ketosis. We revisit the man, the legend, Odo Warburg, and talk
00:02:56.960 about the Warburg effect and Warburg's point of view on these things. And I do push him a little bit on
00:03:03.400 this because I want to point out that it's not entirely clear amongst people what the Warburg effect
00:03:08.460 really implies and how ubiquitous it is. And I have to be honest with you, I don't necessarily share
00:03:13.860 Tom's views on a number of these things. So I wanted to do my best to sort of represent as many
00:03:19.700 other views as possible. But at the same time, I hope the discussion is helpful. We get into a bunch
00:03:23.980 of the semantics. I knew this was a very technical topic, and I know that not everybody has the luxury
00:03:28.500 of listening to this while they're reviewing the show notes. So we do go over the differences
00:03:33.760 between respiration or oxidative phosphorylation and fermentation. It's very important to understand
00:03:38.260 this. So one thing to keep in mind with this podcast, and frankly, any of the more technical
00:03:41.880 episodes we do, if you're struggling with a concept, hit pause. I don't think it's worth sort
00:03:48.080 of going through these not understanding them. I think it's cool to listen to this, hit pause,
00:03:52.580 go back, hit Wikipedia, ping us with a question on social media or whatever if there's a concept
00:03:57.560 that's stumping you. But this is obviously going to be one of the more important concepts.
00:04:00.740 If you can't understand the difference between respiration, oxidative phosphorylation,
00:04:04.660 as it were, and fermentation, then a lot of this won't make sense. We also get into this
00:04:08.700 idea of substrate level phosphorylation, a very important concept, and the fermentation
00:04:13.020 of glucose. We also talk a lot about glutamine. This is something that I haven't spent a lot
00:04:17.600 of time talking about in the past. I think I do touch on it a little bit with Dom D'Agostino,
00:04:21.700 but we get into it in much greater fashion. And we, of course, get into ultimately the fundamental
00:04:28.840 question that I think people who are interested in metabolic therapies for questions have to be
00:04:33.540 able to answer, which is, is cancer primarily a metabolic disease, meaning a disease whose origin
00:04:39.680 arrives in the mitochondria or in the metabolic machinery of the cell? Or is it primarily a genetic
00:04:45.660 disease where sometimes you will and sometimes you won't sustain mitochondrial damage? Now, I have to,
00:04:53.860 you know, and you'll see this in the interview. It's not entirely clear to me that I buy the argument
00:04:57.840 that cancer is entirely a metabolic disease, though, as some of you will know, I am very
00:05:02.680 bullish on the use of metabolic therapies in cancer, but I'm also very bullish on the use of
00:05:08.100 immunotherapy in cancer and, when appropriate, chemotherapy in cancer. So, you know, my view is
00:05:13.620 that cancer is about as hard a disease as there is ever going to be to target, and therefore, we ought
00:05:18.860 to turn our attention to as many legs of the stool as possible and not just one. I think the discussion
00:05:24.600 gets a little bit heated at one point when I take issue with something Tom said about suggesting that
00:05:31.040 biopsies could exacerbate cancer. I really don't want anybody to come out of this believing that
00:05:37.540 having a biopsy is going to increase their risk of metastatic cancer. I think that anyone's entitled to
00:05:43.760 a hypothesis, but to my knowledge, there are absolutely no evidence to support that claim.
00:05:48.480 We talk a lot about a particular type of cancer called glioblastoma multiforme, GBM, also known as
00:05:56.340 a grade four astrocytoma. This is, of course, a cancer that if you haven't heard of it, you've
00:06:01.300 certainly heard of its effect. John McCain, who recently passed away, suffered from this. I lost a
00:06:07.600 friend to this when I was younger, and I think that if you know somebody who has died of brain cancer,
00:06:12.800 the chances are there's a pretty good chance this is the cancer they had. This is one of those
00:06:17.040 cancers that gives cancer a bad name, and in all fairness, I don't think there's ever been a true
00:06:22.480 documented survivor of this cancer. It also may provide one of the more interesting model systems
00:06:28.220 to study metabolic therapies for cancer. I guess the most important thing we close with is I sort
00:06:33.860 of pushed Tom a little bit on what experiment he would want to see or do to advance the thinking in
00:06:39.680 this field. In many ways, Tom's a little bit of a guy that's on the sidelines of, you know,
00:06:44.600 sort of mainstream cancer. These views, these metabolic fuels, unfortunately, unfortunately,
00:06:49.320 in my view, don't get the attention they deserve. And other people that I'm going to be talking with
00:06:54.700 in the future, such as Sid Mukherjee and Lou Cantley, are going to be some, I think some of the people
00:07:00.080 who are now starting to see through their own research, some of the potential applications for
00:07:05.860 these things. And so I think that in many ways, the problems that Tom has been working on for the
00:07:10.980 last 30 or 40 years are very slowly beginning to gain acceptance. And I don't like to use the word
00:07:17.560 mainstream, but in, I think you know what I mean, in the more mainstream circles of oncology.
00:07:22.040 This interview does get technical at times. And so as is the case with virtually all of our
00:07:26.460 interviews, please pay attention to the show notes if you're having difficulty, if for no other reason
00:07:31.000 than the fact that a heck of a lot of work goes into preparing them on the part of our analytical team.
00:07:35.880 If you like this podcast, I would ask of you very kindly to go and leave a review at iTunes.
00:07:44.620 And I suppose if you don't like this podcast, you can also do that. Lastly, if you are interested
00:07:49.900 in receiving a weekly email, which comes out every Sunday morning from me, that usually talks about
00:07:54.900 something I've done that week, something I've learned that week, something that is hopefully of
00:07:59.300 interest to you. By all means, sign up for that at peteratiamd.com. And I think that's pretty much
00:08:06.360 all I want to say as we go into this. So with that said, please give it up for my guest today,
00:08:11.320 Dr. Tom Seyfried.
00:08:15.660 Hey, Tom, how are you?
00:08:16.860 Well, thank you very much.
00:08:17.940 Well, thank you so much for making time. I know you've got a long lineup of students outside your
00:08:22.600 office here who are kind of pissed at me for sitting here taking up time when you could be answering
00:08:26.640 their questions. So they'll recover. You know, a lot of people have been sort of reaching out to
00:08:33.700 me on social media and saying, you know, you've got to have Tom on, you've got to have Tom on,
00:08:36.720 you know, the podcast with Dom was excellent, but there's so much more we want to understand
00:08:39.780 about cancer. And, you know, certainly cancer is something near and dear to my heart. I did my
00:08:44.480 fellowship in oncology. And, but at the same time, I think I understand cancer far less than I
00:08:49.360 understand things that I didn't formally train in. Like, I think I have a better understanding,
00:08:52.780 for example, of heart disease than I do of cancer. So I'm really excited to explore a lot
00:08:57.560 of topics today and acknowledge that we probably won't even scratch the surface of all that you
00:09:02.720 think about. But all that said, how did you get interested in this?
00:09:06.260 We started it when I was at Yale University Department of Neurology, where we had been
00:09:10.540 working on epilepsy and lipid storage diseases and gangliosides, basically, as a complex lipid
00:09:16.360 molecules. And one of the individuals that I was working with at that time, Robert Yu,
00:09:21.700 was my mentor at the time, he had done some research on ganglioside changes in tumors.
00:09:27.220 And, you know, we had been looking at that. And I said, you know, there was some interesting
00:09:31.860 molecules in those tumor cells. So I also knew Dennis Spencer, who was the chief of neurosurgery
00:09:39.100 at the time at Yale. And he said, why don't you come up to the operating room with me and I'll get
00:09:45.240 you a nice piece of glioblastoma from a patient. And, you know, I'm a basic scientist. I'm not a
00:09:50.360 clinician. I don't know what's going on. So I said, sure. He'd come into the operating room.
00:09:55.380 And it was kind of an experience that I'll never forget, having someone take a tumor out of
00:10:00.740 someone's head. And they were asking me all kinds of questions like, you know, do you think we should
00:10:04.840 put pellets of radiation in the cavity and, you know, all this kind of stuff? And of course,
00:10:09.220 I didn't know. I said, I'm here to look at the ganglioside pattern in the tumor. I don't know how to treat
00:10:13.940 the cancer or anything like this. But in any event, we had then started making our own brain
00:10:19.460 tumors in the mouse based on the work of Harry Zimmerman, who started the first school of
00:10:24.700 neuropathology in the United States at Yale University in the back of the 1930s. And he was
00:10:29.340 still alive at the time. He lived to be 98 years old or something. So I was interested in doing
00:10:35.360 comparative studies of glycolipids in human and mouse brain tumors to see whether or not we can come to
00:10:42.860 some common changes. And that's how we got started, pretty much looking at comparative
00:10:48.560 biochemical profiles between human tumors and mouse tumors. And there was some similarities,
00:10:53.720 but there were many differences as well. But we didn't get into the kind of therapeutic
00:10:58.260 evaluation of these tumors until we also had a huge program in epilepsy, mapping genes for epilepsy.
00:11:05.200 We did a lot of things at Yale. Everybody's working on the glycolipids of the tumors,
00:11:09.220 glycolipids of developing brain, lipid storage diseases, and epilepsy. And I wrote a grant
00:11:16.820 internally at Yale, which was rejected, asking about ketogenic diets.
00:11:22.940 And what year was this?
00:11:23.780 This was back in the late 70s, early 80s, maybe, 1980. And they said, oh, nobody's interested in
00:11:31.100 ketogenic diets. It's kind of passe.
00:11:32.860 This was before the work at Hopkins or?
00:11:35.960 Yeah. Hopkins, John Freeman was a friend of mine too, who was the godfather of ketogenic diets.
00:11:41.980 He was the one that saved Jim Abrams' son, Charlie. And Jim was a movie director. And his friend,
00:11:49.460 Meryl Streep, made the movie, First Do No Harm, which was based in part on Jim's experience with
00:11:56.840 his son. But I wasn't connected at that time to Abrams or any of that stuff. That was even before
00:12:02.180 the Charlie Foundation. I just had this inkling that maybe ketogenic diet would be interesting
00:12:07.460 to test against some of the epilepsy models that I was working with.
00:12:10.580 But does that mean you suspected that something to do with glucose metabolism was-
00:12:14.720 No, nothing. I just thought it was an interesting approach to a non-drug approach for seizures.
00:12:21.200 And anyway, the grant was summarily rejected. So I said, well, nobody's interested in this.
00:12:25.300 So I left Yale and I came up to Boston College here, start a program. And then we were here from,
00:12:30.700 then it was 10 years, 15 years later when we developed some of the best animal models for
00:12:35.780 epilepsy. And we were looking at brain biochemistry and epileptic seizures and the genes that caused
00:12:41.720 epilepsy. And then one of my PhD students, Marianna Tran, says, oh, they're having a big meeting out
00:12:46.900 in Washington on ketogenic diets for epilepsy. And maybe our model would be appropriate for this.
00:12:52.840 I said, nah, this is, you know, I says, after my experience at Yale, I said, nobody's interested
00:12:58.040 in this crap anyway.
00:12:59.440 You're still traumatized by the grant.
00:13:01.440 Yeah, yeah, yeah. So I said, they're not in, you know, I got a summarily rejected that says,
00:13:05.280 this is nobody interested in ketogenic diets. So anyway, she said, hold on a minute. So I said,
00:13:10.020 I had a few extra bucks in the grant. So I said, okay, go on out there. In fact, she wrote a little
00:13:14.620 blurb and they funded her to go out there. So she comes back and starts telling me about, wow,
00:13:20.620 you can't believe what I saw out there. All these guys are interested in this ketogenic diet. And
00:13:24.700 this guy, Jim Abrams, and he wants to start this foundation called the Charlie Foundation. And it
00:13:31.140 was like to study epilepsy and ketogenic diets and stuff. So I said, all right, what the hell? So we
00:13:37.260 started to put them on the mice. And it was funny because we didn't know what we were doing. But then
00:13:42.420 at the same time, it was, two things came together at the same time. We were studying gangliocytes for
00:13:47.900 lipid storage diseases. And there was a drug company over in England that gave us this new
00:13:51.640 drug that was supposed to stop ganglioside synthesis and therefore reduce the storage in
00:13:55.980 the brain. Of course, at that time at Boston College, they didn't charge me for animals,
00:14:03.300 which they do now, which is a tragedy because you can really do a lot of work. The damn mice cost so
00:14:07.860 much money. And there were so fewer restrictions. I mean, we'd followed all of the animal care
00:14:12.380 protocols, but we had access to a large number. So we could do experiments that you
00:14:17.140 couldn't do anywhere else. So when we got the drug from the company, we were feeding the drug to the
00:14:23.080 mice. And we looked at the ganglioside. Yeah, it's really down. But so was the body weight. And then
00:14:27.860 when we put the control group in, we found out that, yeah, the tumors shrunk and the gangliosides
00:14:32.740 were reduced from this drug. But then the body weight was also reduced.
00:14:37.220 And the controls were also, they're both animals being fed ad lib?
00:14:40.380 Ad libidum. One had the drug, one didn't.
00:14:42.720 Okay. So the drug somehow either reduced intake or increased expenditure.
00:14:46.240 We don't know, but it's the body weights were reduced by about 15 or 20%. So, and the tumors
00:14:51.560 were significantly reduced by about 50, 60%. So I told the company that, you know, I just threw
00:14:56.880 them on. I just, this was a pilot study. I told the company that your drug seems to really shrink
00:15:01.560 brain tumors. And they go, wow, Jesus, this is a much bigger market than say Tay-Sachs disease,
00:15:06.560 right? So that's when they gave me $200,000 to investigate the mechanism by which their drug was
00:15:13.520 stopping brain cancer. Because I showed them the data and they were, they were all excited.
00:15:17.920 So we then began to investigate this and Perna Mukherjee, Dr. Mukherjee who worked, started with
00:15:22.900 me. I said, hey, Perna, I hired her specifically to start looking at this. And then when we realized
00:15:28.820 that, you know, what's, what's working? She said, you know, a lot of times these drugs work through
00:15:34.040 calorie restriction. So I said, well, why don't we put a control group? We all decided, let's put a
00:15:39.620 control group for body weights. And then we just, one, one was the, the guys with the drug and losing
00:15:45.220 weight. The other guys would just take the food away from them. So the body weights would be
00:15:48.360 absolutely identical. So they were pair fed. It wasn't pair fed. One, uh, one group was eating
00:15:53.600 ad libitum and they were losing body weight. And the other group, uh, we had to restrict the
00:15:59.160 calories to match, to match the body weight. So they were, they're pair weighted. Yes. And it weighted.
00:16:04.280 And then we evaluated this and the tumors were exactly the same size. So it had nothing to do
00:16:09.780 with the drug. Even though the drug was working on the targeted molecule, it wasn't the targeted
00:16:14.760 molecule that was, was responsible for this. So that's when we also decided with the epilepsy
00:16:21.660 overlapping, does the cat, does the ketogenic diet work through calorie restriction? Because many of
00:16:26.400 these children that get ketogenic diets, they have a very restricted calories and you have to,
00:16:30.560 you have to give, um, very small, you can't let kids eat massive amounts of fat because invariably
00:16:37.220 John Freeman told me it doesn't, the diet doesn't work if they just like one out of two or 300 kids
00:16:41.960 just loves to eat all this fat and the, and the seizures don't go away. So we, in other words,
00:16:46.980 the, the thinking at the time was there is some amount of caloric restriction that is necessary
00:16:51.620 within the context of the ketosis to also affect the epileptic seizures. Yes, absolutely. But you have to
00:16:57.780 be very careful because many of these children are on the growth spurt. So you have to be careful
00:17:01.680 on how much restriction you give. And the other thing, of course, it's self-restricted. There's
00:17:06.100 several physiological systems in our body that when you eat a lot of fat, you just don't eat a lot of
00:17:10.600 calories. It's a turnoff. It works through the vagus nerve. The hormone cholecystokinin is kind
00:17:16.680 of an appetite suppressor. It affects the vagus nerve, which then stops the appetite. You don't eat as much.
00:17:22.100 So I have so many stories. So I was sitting on a bus one day.
00:17:26.480 You're on the right podcast, Tom, because we don't have time restrictions.
00:17:30.080 Yeah, but listen, so they made this thing called the vagal nerve stimulator. And it was made by a
00:17:36.320 company. I can't remember the name of it. Made a fortune. They would implant the stimulator into
00:17:40.680 the persons who has epilepsy and it would send out things to stimulate the vagus nerve. And I was
00:17:46.420 sitting on the bus with this guy from Norway. And he says, I said, you're putting this in the
00:17:49.700 patient. Yeah, we're putting this in the patients. How does it work? Yeah, it seems to work really
00:17:52.700 good. I said, how much is it? He says, well, the operation is like $4,000, but the device,
00:17:59.420 it was like $15,000 or $16,000. But they were putting them in all these epileptic patients and
00:18:04.220 they're working. I said, how does it work? He said, I don't know, but it works. So I said,
00:18:07.620 I didn't know. I'm sitting on the bus. I don't know. We're going to MGM Studios down in Florida.
00:18:12.660 They closed the whole place down in the middle of the week in December so that they could attract all the
00:18:19.520 epileptologists to use their device to put into these patients. It's one of these kinds of things.
00:18:24.140 So anyway, it comes back when we were working on ketogenic diets and calorie restriction,
00:18:28.540 we realized that humans have this internal system to stop calories. And if you don't stop the
00:18:34.700 calories, invariably, you don't get the management of the seizures. So we, in our parallel studies in
00:18:41.960 epilepsy with mice and cancer and all this other stuff, we started to learn what's working in the
00:18:48.680 patients. How do we translate what's working in the patients into the mice? The mice can be another
00:18:53.460 source of information that we can feed back. And we published this big paper on calorie restriction
00:18:59.080 and that the ketogenic diet was working largely through calorie restriction and maintaining low
00:19:05.040 blood sugar levels was the key to maintaining control of seizures.
00:19:08.820 Now, if you had a, I don't know if you did this experiment, but if you took animals on an equally
00:19:13.320 low caloric diet that was not ketogenic, so let's just say a very high carbohydrate, low fat diet,
00:19:19.880 where presumably glucose levels would be higher, even though they would still be calorically
00:19:23.980 restricted, would you get the same anti-seizure benefit?
00:19:26.680 The same results. Exactly. So because what was happening is that when the body is restricted of
00:19:31.640 calories, you then make ketones. So the level of ketosis was also seen in the calories. It would be
00:19:37.560 like a human doing what are only fasting.
00:19:39.440 So how calorically restricted did they need to be if they were not on a ketogenic diet?
00:19:43.980 40%, 30 to 5 to 40% restriction. And then we did some studies, another group, we found out that
00:19:48.900 35 to 40% restriction of calories in the mouse equates to a water-only therapeutic fasting in
00:19:55.540 humans. And that's because the- Yeah, their metabolism is-
00:19:58.640 Right, seven or eight times higher than that of a man. So humans can achieve much higher ketosis than a
00:20:03.900 mouse can. And the mouse, so one week, a one-day water-only fast in a mouse is like a seven-day
00:20:10.000 water-only fast in a human. And the blood sugars go down, the ketones go up.
00:20:13.540 IRBs don't allow you to fast mice that long anymore, do they?
00:20:16.860 Oh yeah. I mean, as long as they're healthy. Calorie restriction is generally a healthy thing.
00:20:23.000 You don't want to over-restrict because then you put into a nutritional imbalance and you don't want
00:20:28.360 to go to the level of what we call starvation. This is another. Calorie restriction is healthy
00:20:33.620 up to the point where you start breaking down muscle. If you start breaking down muscle,
00:20:37.560 then you enter into a new physiological state called starvation. And that's very pathological.
00:20:43.180 You don't ever want to go to that digression. So some people, they get so carried away with
00:20:47.720 water-only fasting, they can enter into starvation mode. And I know this for a fact because I used to
00:20:53.260 spend a lot of time with George Cahill, who used to run the Joslyn Diabetes Centers down here in
00:20:57.960 Boston. And he and I would talk for hours and hours with Bud Veach at the NIH about how long
00:21:03.240 people can go with this transition over from therapeutic fasting into starvation. And also
00:21:09.360 the body builds. It's like anything. Your body gets accustomed. You can go a long time without
00:21:14.400 eating if you're in shape, if you've done this. But it depends on what your body weight is,
00:21:19.840 how old you are. It depends on a lot of different things, how long you can go without eating.
00:21:24.360 But the bottom line is that we were trying to develop a therapy and figure out the mechanisms
00:21:30.540 by which ketogenic diets were therapeutic. Now, going back to the Cahill stuff for a moment
00:21:35.500 before we come back to that, did you have a sense or did George have a sense of when those patients
00:21:41.400 are in a negative nitrogen balance? And I assume it matters as to what their starting weight is and
00:21:46.800 muscle mass and things like that. But were there general rules about once you cross over that point
00:21:52.420 where you're basically pulling nitrogen out of the muscle?
00:21:56.280 Right, right. And he got those data actually from the 10 guys that starved to death in May's prison
00:22:02.180 in Northern Ireland, Bobby Sands and that group actually. He was there monitoring their blood
00:22:07.480 work while they were dying of starvation.
00:22:10.280 These were prisoners that they were fasting as a protest, correct?
00:22:14.280 Yes. They made a movie out of it, Every Mother's Son, about it. There was 10 Irishmen that were-
00:22:20.080 How long did they live on average?
00:22:21.740 They averaged, I think, he had the data. He was never able to publish it. The British government
00:22:26.560 was on top of him about that. But he was able to collect the data and shared some of that stuff.
00:22:32.460 It was very interesting. It's a horrible thing. It's like one of the worst ways to die is starvation.
00:22:37.420 So what happens, your diaphragm is the last muscle that will be digested. And there's a momentum
00:22:43.700 that starts. Now you have to realize that these guys that did this-
00:22:48.700 So they don't die of just acidosis. It's actually the-
00:22:52.380 You drown in your own body fluids, basically. Jeez, it's brutal. Because what happens is once your
00:22:58.660 diaphragm can't work, your lungs fill up with fluids and you drown in your own fluids.
00:23:04.020 And the diaphragm presumably stops working because of either the loss of muscle or the
00:23:08.260 electrolyte imbalance.
00:23:09.440 Yeah, both. A combination of both. And then you can't stop it. Once the momentum starts-
00:23:16.220 It's like these horrible hiccups, right?
00:23:17.540 Yeah. Well, once the momentum starts, it seems like they try to do an intervention
00:23:22.020 on a couple of the guys and they weren't able to reverse it. So it was pretty horrific.
00:23:27.040 Now, those guys were all young Irishmen, you know, in their 20s and 30s. I don't know what
00:23:32.580 the oldest guy was, but they lived from, I don't know, 68 to, I don't know, 85, 90 days without
00:23:38.680 any food, just water. But then he subsequently fasted these very obese people.
00:23:44.100 For 40 days?
00:23:45.140 Longer, for six months, eight months.
00:23:47.000 Oh, wow.
00:23:47.480 Yeah. He has the data. One guy, a postman, lost his job, weighed 450 pounds or something,
00:23:53.680 couldn't deliver the mail. So they put him on the water-only fasting for six months,
00:23:59.260 I think, six or eight months. Guy lost 250 pounds.
00:24:01.860 This is different from the guy who, there was a single case report of a patient who weighed
00:24:07.160 a little over 400 pounds and did a 382-day fast.
00:24:11.000 Yeah.
00:24:11.160 But I didn't realize that was Cahill that was overseeing that.
00:24:13.520 I don't know if that was Cahill. There was another, there's a couple of them.
00:24:16.980 Okay.
00:24:17.360 But he was overseeing, he showed us the data on this one guy, the postman. And, you know,
00:24:23.620 and the issue, of course, is I don't know if he took many supplements because your body fat
00:24:28.080 holds a lot of vitamins, fat-soluble vitamins. The minerals come from your bones. The liver
00:24:33.240 holds an awful lot of B vitamins and things like this. I think there were supplements over the
00:24:38.360 course, but they weren't, you don't need a lot of supplements. Your body holds a lot. We evolved
00:24:43.080 as a species to starve. I mean, our existence today is dependent on our ability to go long
00:24:49.460 periods of time without eating. We don't receive that anymore, but-
00:24:53.480 Yeah, yeah. And it seems that our ability to access minerals and vitamins is highly dependent
00:24:59.960 on our nutritional state. In other words, your need for those things tends to go up in a fed state.
00:25:05.500 Yeah. At least according to some research I've seen.
00:25:09.240 Yeah, you're right. And our ancestors were hardened people. You know, their bodies were
00:25:14.260 already acclimated to a starvation mode. So they were very efficient in maintaining mineral and
00:25:20.560 nutrient balances. I think in our society today, and this is purely speculation, I think a lot of the
00:25:25.980 foods are depleted in the kinds of nutrients that we would need. Therefore, some people are almost
00:25:31.320 like in a starvation mode, but they're eating food that has no nutritional value. And consequently,
00:25:36.980 you store a lot of fat. Because the body doesn't usually get rid of sugar. You know, as I said,
00:25:43.160 sugar is stored. It's not, you know, pee out sugar unless you have type 1 diabetes or something.
00:25:48.200 The body has all these filtration systems to keep carbs, which is then transferred to fat
00:25:53.080 and stored as fat. That's our energy to keep us alive when there's no food. But all these ideas and
00:25:59.440 things were developing when we were doing the epilepsy studies. And it became clear that calorie
00:26:04.600 restriction was a key mechanism by which the ketogenic diet was working. And we have since
00:26:10.140 then seen in numerous children with epilepsy that breakthrough seizures will occur when blood sugar
00:26:16.660 spikes. Define spike in that very specific case. How high does it need to be in milligrams per
00:26:21.480 deciliter? Yeah, it doesn't really, for managing epilepsy, there's many cases where it just has to go a
00:26:25.840 little bit above the baseline. So kids will have a very low 70, 68, 65 milligrams per deciliter.
00:26:33.240 They'll grab a cupcake at a party or whatever and spikes up to 120 or whatever. And then you'll get
00:26:38.780 a breakthrough seizure. And do you believe that it is the absolute value of 120 in that case? Or do you
00:26:44.740 believe it's the D by DT, like meaning the rate of change of the glucose? We can't know that. It hasn't
00:26:50.820 been done effectively. All we know is from the clinicians and the nurses that have told me all
00:26:55.580 this information. And of course, when your child has a breakthrough seizure, nobody likes to see a
00:27:00.880 kid seizing. I mean, it's traumatic. It's not a pleasant thing. So once they realize that the kids
00:27:07.660 have to maintain this very stable, the parents are very, very restrictive of these kids because they
00:27:15.180 don't want to see their child seize. So they're very restrictive. So when we do the same thing for
00:27:19.700 cancer, the problem with cancer is you don't see a breakthrough seizure. You don't see a group of
00:27:25.660 tumor cells starting to grow faster. You don't see the immediate effects, but they're there, but you
00:27:30.020 just can't see them. With epilepsy, you have a very visible, clear indication that something went wrong.
00:27:35.880 And invariably, there's a spike in glucose. Now, what's very interesting is in these kids,
00:27:40.360 they could be maintained for months without a single seizure. And then one drink of a grape juice
00:27:45.840 or whatever the hell, boom, breakthrough seizure within sometimes minutes from the time you took
00:27:50.800 the... So it's a very, they can flip back, but then they can also get back on track again. They don't
00:27:55.740 have a large number of seizures. They can just, they can get back on track. But it's a very sensitive
00:28:00.520 system in our brains. And as John told me, John Freeman, he says, we don't understand that if a kid
00:28:06.780 has maintained seizure-free or minimal seizures for long periods of time on ketogenic diets,
00:28:13.020 and then we remove the diet, they seem to be managed. In other words, they don't return to their
00:28:18.980 multiple seizures that they would have had every day. So he doesn't know if it was because the diet
00:28:24.320 did something fundamental or they outgrew the seizure or whatever. It was, again, these are areas
00:28:30.060 in epilepsy that are under active investigation by a lot of...
00:28:32.840 But it's interesting. It's almost like a reset, right? I mean, one of the things that impressed
00:28:35.820 me about reading the case studies of these very, very long fasts is that in the reports
00:28:42.360 that are published several years later, many of the subjects maintain their new weight-reduced state,
00:28:49.540 which is a bit counterintuitive based on what we know today about traditional dieting approaches
00:28:55.180 where everybody sort of will return back to baseline. And so it begs the question, right? When you starve
00:29:01.100 this person for six months, do they completely change the way they eat on the other side
00:29:06.400 because of a behavioral shift or is it a physiologic shift, meaning their metabolism has been kind of
00:29:11.660 quote-unquote fixed?
00:29:12.560 Yeah. Well, I think it's probably a combination of both. I mean, again, these are very complicated
00:29:16.660 physiological processes. You know, they call it the thrifty gene. That was a term. It's not one
00:29:22.360 gene. It's like the thrifty physiology. If you do yo-yo dieting, I mean, you can be screwed up for a long
00:29:27.460 period of time. Those things all have loose ends. There's nothing that we have found that's absolutely
00:29:34.940 consistent in all patients all the time when it comes to those kinds of things. And that's why
00:29:40.780 they're always interesting to talk about because someone always has some new people, new idea about
00:29:45.200 something that they've seen. It kind of fits in a little bit with what everybody else is. I don't
00:29:49.960 really dwell, engage in those kinds of things as far as our research is concerned. You know, we know
00:29:55.080 about them. We talk about them, but we don't, other than the calorie restriction that we introduce
00:30:00.140 into the mice. And then when we found out that the calorie restriction and the ketogenic diets were
00:30:05.080 working. So people say, well, why don't you just do calorie restriction? Because, you know, cancer,
00:30:10.140 back to cancer, we don't like to restrict. The term restriction, even the term, you already got a
00:30:16.600 disease, now you have to be restricted. You know, it's like, so ketogenic diets are a little,
00:30:21.240 takes the sting out of a therapeutic fast. And they can also replicate some of the same
00:30:26.100 physiological changes. The key is to lower the blood sugar and elevate the ketones. And that's
00:30:31.400 what ketogenic diets do for managing epilepsy. And they do the same thing for cancer. The issue,
00:30:37.700 of course, is we don't know the mechanism by which lowering glucose and elevating ketones is
00:30:43.340 responsible for the management of the seizure. This is under an active investigation by a lot of labs.
00:30:49.020 The actual mechanism. Is it the elevation of the ketones? Is it the reduction of the glucose?
00:30:53.860 Or is it some combination of the two? But for cancer, it becomes very clear. The mechanism of
00:30:59.680 action is very clear for how this kills cancer cells. It's based on Otto Warburg's theory.
00:31:06.480 So when we started to do this and realized that calorie restriction was shrinking these tumors down
00:31:11.800 massively, you know, based on the drug that I told you about, because it was working through
00:31:16.880 calorie restriction. Then I said, you know, how is calorie restriction stopping tumors?
00:31:21.620 And then we realized that it was lowering blood sugar. So we started measuring blood sugar in
00:31:25.760 these calorie-restricted mice and measuring ketones. And we were seeing that we were getting
00:31:30.520 these major shifts. And then we said, you know, then it became clear who was the guy who did this
00:31:34.720 or thought about. And it was Warburg. Now, he wasn't doing ketogenic diets. Had he done and known
00:31:39.440 about that, I think he would have been able to crack this cancer thing far, far earlier than it.
00:31:44.340 He didn't do ketogenic. He didn't know anything about that.
00:31:46.740 So let's back up for a moment for people. I mean, I think most people listening probably know what
00:31:50.500 the Warburg effect is and who Warburg was. But maybe just give us a moment of setting the stage
00:31:55.780 for what his observation was that now bears his name.
00:31:59.200 Well, his interest was in biochemistry. He was a classical chemist, biochemist in his time.
00:32:06.440 And he began to look at the metabolism of tumors. So he made an observation which was solidified
00:32:15.380 that cancer cells continue to do an ancient fermentation metabolism, even in the presence
00:32:21.620 of oxygen. So this, the Pasteur effect from Louis Pasteur with the yeast was that, you know,
00:32:27.480 yeast will ferment. They evolved. That organism evolved to be able to ferment, get energy in the
00:32:32.460 absence of oxygen. But when, as soon as oxygen came into the presence, they stopped fermenting
00:32:37.720 and they immediately started respiring. They have a system that can do that. So the Pasteur effect
00:32:42.800 was basically the termination of fermentation in the presence of oxygen. That was the Pasteur effect.
00:32:48.180 And it was repeated in all these yeast strains and this kind of thing. And that was a fundamental
00:32:52.780 biochemical advancement, so to say. But Warburg recognized, he knew Pasteur's work very,
00:32:58.820 very well. And then he said, geez, these cancer cells, man, they continue to throw out lactic
00:33:03.120 acid, even in the presence of 100% oxygen. So he grew cancer cells in 100% oxygen. And they were
00:33:10.040 still making lactic acid. So clearly, the Pasteur effect wasn't working.
00:33:14.300 I'll just interject for a moment to explain something to the listener. And we'll probably
00:33:17.220 have a picture of this. But of course, you take glucose to pyruvate in the cytoplasm.
00:33:22.160 Right.
00:33:22.360 And that's a, you know, that yields a couple of units of ATP. And then you have sort of a choice
00:33:27.080 of what you're going to do with that pyruvate. If your demand for ATP is incredibly quick,
00:33:32.420 usually exceeding the capacity of oxygen to get into the cell, you'll make lactate.
00:33:36.860 And that's also relatively inefficient, meaning you don't get that much more ATP. I think you get
00:33:41.160 another two molecules of ATP per unit of pyruvate. But at least you have the advantage of saying,
00:33:46.980 I'm not limited by oxygen. Alternatively, if you, if oxygen is plentiful, and more importantly,
00:33:52.240 if the demand for ATP is not excessive, you can shuttle that pyruvate into acetyl-CoA in the
00:33:58.060 mitochondria, and you can generate over 30 units of ATP.
00:34:01.500 Right.
00:34:01.720 And so what you're saying is there is an observation which said, hey, if I put this cell in the presence
00:34:09.400 of lots of oxygen, it really shouldn't make much lactate.
00:34:13.640 Right. And that's what he finds when you take normal tissue like kidney slices or muscle slices or
00:34:19.040 liver, you'd grow them in 100% oxygen, and they produce minimal, barely detectable lactate.
00:34:26.520 There's always some going to be produced in every tissue, but basically it's very minimal,
00:34:30.840 very minimal. But the cancer cell continues to dump out massive amounts of lactic acid,
00:34:35.940 even in the presence of 100% oxygen. So this was a phenomenon. And he saw this over and over again.
00:34:43.080 It didn't make any difference whether it was a human tumor, a mouse tumor, a rat tumor.
00:34:46.880 They were all doing this same kind of thing. So what he concluded from this was that their
00:34:53.420 respiratory system was defective. Because like you just said, if pyruvate, now that's the end
00:34:59.120 in Meyerhoff pathway going from glucose to pyruvate. Pyruvate is the end of that. So then the opportunity
00:35:06.820 is that the pyruvate would enter into the mitochondria under oxygenated conditions and be fully oxidized
00:35:12.680 to water and CO2. And oxygen is the acceptor of the electrons to form the water. And the carbons
00:35:20.760 are coming from the foods that we metabolized. But the cancer cell was dumping out large amounts of
00:35:26.720 this lactic acid. So why would a cancer cell dump out lactic acid? And it became clear to Warburg
00:35:32.600 through a variety of experiments that the respiratory system was defective in these cells.
00:35:37.460 Let's just clarify that. Many people, when they hear that, we think respiratory system,
00:35:41.820 we think of lungs. What you really mean is the mitochondrial machinery that undergoes what we
00:35:47.100 call cellular respiration. The lungs are bringing in the oxygen and getting rid of the CO2 that enables
00:35:53.140 mitochondria. That enables all the cells and the majority of our cells in the body to perform this
00:35:57.700 very efficient form of energy production, which then frees up the cells to do their sophisticated
00:36:04.420 behaviors. Liver cells do what they do, kidney cells, brain cells. They all do what they do because
00:36:10.300 they have this very efficient energetic system that's working called respiration. The lungs are
00:36:15.780 just the facilitators of the body to get the good air in and the bad air out. So basically,
00:36:22.100 the cancer cell was continuing to produce massive amounts of lactic acid despite the fact that there
00:36:28.060 was all this. So he was then looking at the mitochondria, noticing that there were some
00:36:34.000 defects and these kinds of things. But he wasn't at the level of electron microscopy or this. He just
00:36:40.060 made the- What year? This is in the 1920s? Mostly late 20s, 30s, 40s, all the way up to the 50s. I think
00:36:46.760 he stopped his research maybe in the early 60s. Now, he won a Nobel Prize, didn't he? Yeah.
00:36:51.860 Was it for the description of this phenomenon? No. It was for the discovery of cytochrome C oxidase,
00:36:56.540 which is actually one of the key enzymes in the electron transport chain. How cells generate energy
00:37:00.860 through respiration. So he was nominated other times. And there's still some controversy about
00:37:07.160 how many times he had been nominated for the work on cancer, but never to achieve another Nobel Prize.
00:37:14.200 But he was considered one of the dominant biochemists in the 20th century. And he had very strong
00:37:20.460 ideas and very excellent quantitative measurements for this. A lot of his work was reproduced by
00:37:26.400 dozens and dozens of scientists. So that was the fundamental observation. But he then extended
00:37:32.120 this to the theory that why are the cells are producing all this lactic acid? Because the
00:37:37.860 organelle that is supposed to be involved is defective. This led to a lot of controversy.
00:37:43.260 What do you mean defective? How defective? What do you mean? So much later, Pete Peterson from Johns
00:37:48.120 Hopkins had done a magnificent job in collating all this information. And he found that in every kind
00:37:55.120 of a cancer cell, no matter what kind of it is, there was some defect in the number structure or
00:37:59.180 function of the mitochondria. And it could vary. So some cancer cells have very few mitochondria,
00:38:03.840 but they look normal, very few of them. Other tumor cells clearly have a lot of mitochondria,
00:38:09.200 but they look abnormal. So whatever it was, it was something to do with an impairment of the
00:38:13.620 respiratory system within the cell. And if the cell can't generate energy through normal respiration,
00:38:19.280 then it has to ferment. There's no other way they can get the energy. So it became the Warburg effect,
00:38:26.000 which everybody talks about, is one of the biggest problems in this whole thing. Because Warburg in
00:38:31.920 his paper clearly said that aerobic glycolysis, or what they call the Warburg effect, is a secondary
00:38:37.180 problem that's subjected to many, many variances in the environment. But everybody focuses on this.
00:38:43.400 He said the real issue is the damage to the respiration. And everybody says, no, respiration is normal
00:38:47.560 in cancer cells. And why would they say it's normal? Because they started doing cells in culture
00:38:52.860 rather than looking at the tissues themselves. And once you start doing culture work, you're taking
00:38:58.200 cells from a tissue and separating them and growing them as if they were microorganisms in a culture dish.
00:39:04.820 Well, this changes everything. They're no longer connected to each other. They're growing in
00:39:08.120 some artificial fluid. And they're doing things that they sometimes do and sometimes not do in the
00:39:13.820 real world. So you make a lot of assumptions about things based on a system that itself is
00:39:20.020 artifactual. So let me ask a couple of technical questions. Obviously, measuring the amount of
00:39:26.260 lactate or hydrogen ion that's produced is a way to give us an indication of how much anaerobic
00:39:31.420 metabolism is taking place. If you're not in cell culture, how do you quantify the amount of aerobic
00:39:40.080 respiration? You look at the amount of oxygen consumed and the amount of lactic acid produced.
00:39:45.660 So if you're doing aerobic respiration, you're consuming a lot of oxygen and producing very
00:39:51.600 little lactate. And then you can quantitate the amount of ATP being produced per milliliter of
00:39:58.440 oxygen that you consume. And according to this, this can vary from anywhere from seven ATP units to nine,
00:40:05.240 depending on the system. But it's, you know, Warburg used the number seven based on his data
00:40:09.860 at that time. So you could calculate the total amount of ATP being produced in the cell based
00:40:14.380 on its oxygen consumption and its lactic acid production.
00:40:17.280 And Warburg, did he ever do this in situ?
00:40:20.040 Yes. He did it in slices and then he did it in cell culture as well. So he created some of his own
00:40:26.380 problems as well, switching from one to the other. The concern that we have now is that many cells in
00:40:34.120 culture look like they're consuming a lot of oxygen. And they're making lactic acid, but they're
00:40:39.380 consuming a lot of oxygen. So like you said-
00:40:41.880 Suggesting that they're doing both, which is still a bit odd.
00:40:44.340 Yeah, right. Well, that was Sidney Winehouse's argument. His argument was the cancer cell needs
00:40:48.080 so much energy that respiration by itself can't be sufficient. So they have to ferment and respire
00:40:52.880 at the same time. And that made everybody feel that, yeah, Warburg was wrong. They do have good
00:40:59.180 respiration, but they just need so much more energy. They need to ferment at the same time.
00:41:03.620 But the work from Pete Peterson showed that they have defective respiration. So, I mean,
00:41:07.540 they have defective mitochondria, structure, number, and function, besides many other studies
00:41:11.260 have shown. So you know that they can't be doing oxidative phosphorylation or respiration because
00:41:16.420 the very organelle that is needed for that is deficient in some way. And that could be many
00:41:20.800 different ways. As I said, there's no one, all cancer cells, all cancer cells have a defect in
00:41:25.440 respiration. How that defect came about can vary from one type of cancer to another. So one has to
00:41:31.360 recognize that. So not every cancer cell will have the exact same defect in respiration. In the
00:41:37.060 mitochondria, some will have very few mitochondria. Okay. So they just don't have quantitatively enough
00:41:41.960 organelles to do respiration. But what seems to be there seems to be functional to partially
00:41:48.120 functional. Other cells, as I said, are loaded with mitochondria, but when you look at them,
00:41:52.700 they're morphologically abnormal. So structure dictates function. In biology, we know that structure
00:41:58.620 dictates function. So if the structure of the organelle is abnormal, you know that the function
00:42:03.200 of that organelle is not going to be normal. And is the idea that those mutations were acquired?
00:42:09.100 Oh, I wouldn't call them mutations. They would call them defects. Now you can have-
00:42:12.420 In other words, the genome is unaffected in some of those cases?
00:42:15.100 Yes. We've done that. We sequenced the entire genome of five different independently derived
00:42:20.240 cancers from mouse, all derived from different origins. And we didn't find a single genetic abnormality,
00:42:27.100 what we call pathogenic, where the mutation would actually have an effect on a function.
00:42:32.220 And we didn't find a single one. So that told-
00:42:35.660 So let's take, maybe take a step back and for the listener again, we'll go over some of the basics
00:42:40.220 of genetics. Because I think that for many people, there's an understanding that, I mean, by definition,
00:42:46.280 a cancer has a mutation that renders it incapable of listening to normal cell signaling. Do you have a
00:42:53.180 sense broadly of what amount of human cancers arise from germline mutations rather than somatic
00:42:59.740 mutations? It's obviously very small, but I don't know what the number is.
00:43:02.840 Well, they say it's about five to six percent.
00:43:04.980 Oh, it's that high. Okay.
00:43:06.140 You know, and you hear about them, the BRCA1, BRCA2, relief from any P53, you know-
00:43:12.060 Lynch syndrome, et cetera.
00:43:13.060 Yeah, yeah. But when we looked into those so-called inherited risk, we call them inherited
00:43:18.080 risk factors. None of them have ever been 100% penetrant, which means that every person having
00:43:23.440 that gene must express-
00:43:24.540 They're not purely deterministic.
00:43:25.900 Yeah, they're not deterministic. And as Warburg said, there are many secondary causes of cancer,
00:43:30.580 but there's only one primary cause. The primary cause is the damage to the respiratory system.
00:43:35.720 So if the inherited mutation damages the respiratory system of the cell, the probability of cancer
00:43:41.120 is a real possibility. So because everybody who has leaf from many tumors or BRCA1 tumors or
00:43:47.940 whatever, they're all fermenters. So the fermentation metabolism is there in every cancer.
00:43:54.700 But there are some people that have the exact same mutation that the other person has, but they
00:43:58.800 never develop a tumor because for whatever reason, in that person, that mutation did not damage the
00:44:04.620 respiration. That could be an environmental suppressive effect or another gene in the genome that
00:44:10.220 prevents the inherited mutation from damaging the respiration. We don't know that. So we only know
00:44:16.680 that you don't get cancer if your mitochondria remain healthy. That's what we know. So that's
00:44:22.060 an important, because that goes back to the prevention issue. You know, how do you prevent
00:44:25.140 cancer? You prevent cancer by keeping your mitochondria healthy. How do you do that? Well, you avoid,
00:44:30.200 if you can avoid those risk factors, mostly from the environment, like viral infections,
00:44:36.240 intermittent hypoxia, radiation exposure, carcinogenic exposure, all these different things.
00:44:41.460 Every one of those things can damage respiration in a population of cells, then leading to cancer.
00:44:45.740 Because we know of no cancer that has normal respiration. But when you grow them in culture,
00:44:49.860 people say, yeah, they have normal respiration. They're taking in oxygen. So therefore,
00:44:52.800 Warburg's wrong. But when you look at the structure in the vivo, and you look at the tissues, and you
00:44:56.920 look at the actual architecture of the tissue, invariably, you find damage to the respiration,
00:45:01.060 damage to the structure and function of mitochondria. So what the field has done is put more credibility
00:45:06.720 into the results from cell culture work than into the actual tissues that people see and look under
00:45:10.860 the microscope and look at. Because the Warburg effect was largely forgotten for many years
00:45:15.000 after his initial observation, right?
00:45:17.120 Yeah. A lot of what he did was forgotten. And Pete Peterson was one of the few guys that kept
00:45:21.660 the fire burning. Because as I said, when Watson and Crick discovered the DNA as the origin of the
00:45:28.300 genetic material, but it wasn't only them. There was a whole group of other people that were doing it.
00:45:31.480 They just weren't acknowledged as much. Yeah. And then the field ran off into that. And they also
00:45:37.260 knew that there were chromosomal abnormalities in some cancers. So it made clear that, hey,
00:45:41.480 you know, these genomic defects in the tumor cells are likely the real origin of the disease.
00:45:47.460 So the whole field more or less shifted away from the traditional biochemical analysis to the more
00:45:52.460 molecular biology analysis. And therefore, you find more and more mutations, more and more genetic
00:45:58.640 defects, and all these kinds of things, leading people to believe that these were the causes of
00:46:03.880 the disease. And, you know, a lot of really nice experiments were done where they would introduce,
00:46:08.760 you know, mutant virus particles into cells. And they would integrate into the nuclear genome.
00:46:13.920 And then you'd see the cancer cells lose, become transformed into a neoplastic kind of a cell,
00:46:19.700 making, giving the appearance that this was a cause effect. That if I, they didn't realize that
00:46:25.540 those same viruses went into the mitochondria and blew out the respiration. So that wasn't even
00:46:30.460 considered as possible. But if the viruses are doing that, presumably they're integrating into the
00:46:35.420 genome? Yeah. Well, they would do it both ways. They can do it a lot of different ways.
00:46:38.520 So sometimes the viruses actually infect directly into the mitochondria. They produce proteins in
00:46:43.240 the mitochondria that screw up the electron transport chain. Other times the viruses integrate
00:46:47.840 into the nuclear genome, producing a protein product that then disrupts the mitochondria.
00:46:53.560 Either way, the mitochondria disrupt it, whether if it's a direct effect of the virus replicating
00:46:59.300 inside the organelle, or it's an effect of a product produced by the virus that then goes
00:47:03.720 disrupts the organelle. And this is what we're finding for the majority of these situations.
00:47:09.540 So even the herited mutations that we look at, they disrupt mitochondrial function. And if they
00:47:14.400 disrupt mitochondrial function, you're at risk for developing a neoplasm in that particular
00:47:19.040 population of cells. There are some cancers that don't follow that, correct? I mean, aren't there
00:47:24.600 some cancers that have normal mitochondria? We haven't found any, because the evidence for that
00:47:30.080 is that they're all fermenting. We haven't found a cancer that doesn't ferment. So if the cancer is
00:47:34.660 fermenting, it's obviously not respiring. If its respiration would be normal, it shouldn't be
00:47:40.520 fermenting. As a matter of fact, Dean Burke did this kind of a study way back in the 50s. He went and
00:47:45.400 looked at various kinds of hepatomas, because there was an article that was published to say that there
00:47:49.860 was this very low, slow-growing hepatoma that did not ferment, which was directly related to your
00:47:56.160 question. But Burke, who was at the head of the NCI at the time, studied these things in massive
00:48:01.280 detail and was able to show that the slowest-growing tumor did have a significant elevation of lactic
00:48:09.200 acid production over a normal cell. But you had to look at it really carefully and do the experiments
00:48:14.100 over extended periods of time. So even the slowest of the slowest-growing tumors, guys that would
00:48:19.100 be maybe considered benign, were still making lactic acid.
00:48:23.760 Another interesting thing was the crown gall tumors in plants. This is another interesting...
00:48:30.680 Plants have cancer, but they don't metastasize. They just grow these tumors. And people back in
00:48:35.000 the 30s were testing Warburg's theory in these plants, and they all had damaged respiration.
00:48:39.920 They were fermenting, just like the mouse tumors.
00:48:42.520 When you say respiration, you mean photosynthetic respiration?
00:48:45.520 No. No. Plants have both. Plants can get energy from chloroplasts to build carbohydrates.
00:48:50.220 But they also have mitochondria.
00:48:52.320 Oh, I didn't realize that. So their carbon fixation obviously comes from photosynthesis.
00:48:56.120 Yeah. Yeah.
00:48:57.080 But when they make, you know, their equivalent of starch.
00:49:00.180 Yes. So they will burn their own fuels to generate respiratory energy. But they also have
00:49:06.700 dysmorphic cell growth, and they've called these crown gall tumors. You see them sometimes on the
00:49:11.260 side of trees and things. So people back in the day analyzed the biochemistry of these things. And
00:49:16.800 they also found that they were following Warburg's metabolic profile. But they didn't metastasize.
00:49:23.060 And the reason they don't metastasize is they don't have an immune system. So, and it turns out that
00:49:28.500 from our work and the work of others, the metastatic cell is actually part of our immune system.
00:49:33.120 So macrophages and leukocytes, these are the cells that have the genetic capability of moving around
00:49:39.080 the body, entering into tissues. This is what they do. Plants don't have that. Plants don't have that
00:49:44.220 kind of an immune system. So they don't metastasize. They grow in place. But humans and other animals,
00:49:50.880 of course, that have these cells of the immune system. Therefore, they can get metastatic cancer.
00:49:55.940 So before we get to that, because I do have a number of questions about that topic,
00:49:59.420 another argument that's been proposed for the Warburg effect is the need for cellular building blocks.
00:50:06.040 The other thing that the tumor is doing above and beyond its non-tumorous cellmate is growing.
00:50:12.800 And although not necessarily faster than a regular cell, it certainly grows in a less regulated way,
00:50:17.740 and therefore it's going to proliferate. So van der Heiden and I think Lou Cantlie and Craig Thompson
00:50:23.760 wrote that paper in 2009 that I'm sure you're familiar with. It was a science paper, I believe.
00:50:28.800 And they proposed this other explanation, which was, look, it's not just an energetic thing. In fact,
00:50:34.960 I don't recall if they said it's not just or it's not even about the energetics. But the point here was,
00:50:40.140 this is where you get building blocks to make cells grow. Do you think it's possible that both of
00:50:44.800 these are correct? Yeah. Well, you know, in the process of upregulating the Emden-Meierhoff
00:50:50.760 pathway, you are going to get the carbons for building blocks. At the same time, you're going
00:50:54.960 to get some energy. Now, through the pyruvate kinase system. However, this is very interesting.
00:51:02.440 Now this is, but they deviate from the path from Warburg's theory in saying that respiration is
00:51:07.560 normal. Okay. They think there's nothing wrong with the mitochondria. Okay. They've said that many
00:51:11.740 times. Craig Thompson has said this. You have to ignore a massive amount of evidence to make those
00:51:16.900 kinds of statements. You just have to ignore everything that Pete Peterson has done, which
00:51:20.720 is a life's work showing that the mitochondria, but he doesn't mention that. They don't discuss
00:51:26.560 Pete Peterson's massive amount of evidence. But you're right. In order for a cell to grow,
00:51:31.120 you need a lot of building blocks. And you need carbon. Where's the carbon coming from this?
00:51:34.900 And it's coming from both the pentose pathway and the glycolytic pathway. And it's also coming
00:51:40.000 from glutamine. So these cancer cells are sucking down glutamine. So you're getting the amide nitrogen
00:51:45.380 to form the nucleotides. You're getting the glutamate that then goes into anaplerosis in the
00:51:49.840 TCA cycle. So between glucose and glutamine, you are getting all of the building blocks that you need
00:51:55.520 for rapid cell division. But where's the energy coming from? Okay. Without energy, nothing grows.
00:52:00.700 Nothing can live without ATP. So where is the energy coming from? And this is our thing. So we,
00:52:06.920 myself and Christos Chernopoulos in Hungary, I proposed this a long time ago on a purely theoretical
00:52:14.380 basis, having been convinced that Warburg was right, that the respiration of all cancer cells
00:52:20.700 is damaged to some extent. So if that's the case, the Warburg effect was only the glucose part of the
00:52:27.400 puzzle. It wasn't the glutamine part of the puzzle. So now with our new information, we know that most of
00:52:32.880 the ATP in the cancer is coming from substrate level phosphorylation in the mitochondria, which is
00:52:38.020 disconnected from oxidative phosphorylation. So what we have now is the missing link in Warburg's
00:52:43.640 basic theory. So explain what SLP is. Substrate level phosphorylation is the production of ATP when
00:52:50.920 you move a phosphate group from an organic substrate onto an ADP molecule. So it's an ancient way of
00:52:57.200 generating energy. In other words, it's an organic molecule that's an electronic septor rather than
00:53:02.060 oxygen. Right. So instead of going through the electron transport chain where you use NAD,
00:53:07.720 NADH, NADP, NADPH as electron transporters- Well, electron donors.
00:53:13.020 Electron donors. You can do a very quick trick where you take an ADP and restore it, meaning it
00:53:20.160 has two phosphates. You restore it to an ATP by using an organic molecule to donate a phosphate.
00:53:25.120 Well, for substrate level phosphorylation. Yes. Yes. So succinyl-CoA has a phosphate group on a
00:53:31.640 serine inside the protein itself. And that phosphate group is then donated to ADP, sometimes GDP, make
00:53:38.660 GTP, both. Depends on the situation. But in cancer cells, it's ATP. So you're moving phosphate groups
00:53:44.840 from an organic substrate onto the ADP as the acceptor. And you can generate massive amounts
00:53:51.740 of energy from that process, which can replace the level of lost energy from oxidative phosphorylation.
00:53:57.180 And does that occur inside the mitochondria, inside the inner matrix?
00:54:01.180 Yes. Yeah. It's in the matrix. So you're going to be blowing out a lot of, you're going to make a
00:54:04.860 lot of AT. It's going to just replace. In the normal cell, you're making most of the ATP from
00:54:09.100 oxidative phosphorylation. But in the cancer cell, you're making most of it from substrate
00:54:13.420 level phosphorylation. Inside the same organelle. Why don't our cells do this under demand? So if
00:54:18.980 we jumped up and down and did 25 burpees right now, we would very quickly exceed our oxidative
00:54:24.280 capacity for respiration. And we'd start making a bunch of lactate. Why aren't we also undergoing SLP?
00:54:29.560 Well, we do. In the heart muscles, they do. On various cardiac restrictions and things like that,
00:54:35.600 a lot of this has been worked out in the heart. So it does happen. I mean,
00:54:39.100 we do do substrate level phosphorylation, but it only can be done for short periods of time. It
00:54:44.040 can't be done extensively. You can't replace oxidative phosphorylation under normal conditions
00:54:48.780 with substrate level phosphorylation. You hold your breath, you're going to be able to survive
00:54:52.900 for a certain period of time. Lactic acid builds up. I mean, this was shown by Hoshkatska when he did
00:54:58.840 some incredibly interesting experiments trying to hold various aquatic animals underwater and looking at
00:55:05.020 the metabolic changes that occurred. So seals, porpoises, turtles, you know, these kinds of
00:55:10.460 things. He strapped them to a board, held them underwater, and then he would measure all these
00:55:14.360 metabolites in the bloodstream. Now, these were animals that actually could live underwater. If
00:55:18.480 they did it to us, we'd all be dead, right? We couldn't live that long, but five minutes at the
00:55:21.740 most. But these animals could live 10, 15, 20 minutes being held underwater. And they weren't
00:55:27.360 breathing. Of course, now they were stressed out because they were strapped to a board. But the bottom line
00:55:31.520 is he started measuring all these metabolites in the bloodstream. Lactic acid goes right through the
00:55:35.260 massive amount. I'd expect that, right? So, and succinic acid. Succinic acid is another.
00:55:41.300 So, succinic acid is part of the, in the electron, in the TCA cycle, is a powerful stimulatory towards
00:55:48.640 oxidative phosphorylation. And it was being dumped out into the circulation. So, it wasn't being oxidized.
00:55:55.360 So, he claimed that it was amino acid fermentation that was doing this. So, the body was grabbing amino
00:56:00.900 acids and metabolizing them and generating energy through substrate-level phosphorylation. Well,
00:56:07.260 it turns out the cancer cell is doing this in a massive amount because they don't have the
00:56:10.460 oxfos. So, you look at cancer cells and they're dumping out succinic acid. And succinic acid,
00:56:15.240 it stabilizes HIF-1-alpha. So, you can continue to up the transcription factors for drive and
00:56:20.260 fermentation. So, this whole thing is just a massive shift from oxfos to substrate-level
00:56:26.500 phosphorylation.
00:56:27.220 Does creatine phosphate fit into that SLP pathway or is that totally separate?
00:56:31.080 No, I'm not sure about that. It could be a source of the phosphate groups,
00:56:34.860 but I haven't looked into that. Dominic may know a lot more about that than I do.
00:56:39.560 So, when you go back to sort of, there's an undercurrent here to what we're talking about,
00:56:44.140 which is the view that you hold is the minority view today, it sounds like.
00:56:49.740 Just, it's only, it's just a matter of time. Okay.
00:56:52.480 Why do you think that is? What do you think is the, I mean, I know people want to come up with
00:56:58.200 conspiracy theories and that's sort of one of the things about social media that I find
00:57:01.620 frustrating is people always want a conspiracy theory to be the explanation. Like, oh, the drug
00:57:06.380 companies don't want this to be true or something. I find those things hard to believe. Do you think
00:57:10.460 there's a better explanation for why these hypotheses are not being investigated with the rigor that
00:57:18.400 maybe they should be? Well, you have to look at the discipline of the individuals that are working
00:57:22.060 on the project. Okay. So, if most of the people doing cancer research are molecular biologists,
00:57:26.820 which they are, you have that perspective on the nature of the problem. So, you don't look at
00:57:31.840 respiration directly. You look at gene expression profiles that may be directly or indirectly related
00:57:37.220 to that. And then you make claims about what's going on. So, if most of the people are of a
00:57:42.240 discipline that says that genes are changed and not looking at the actual consumption of oxygen
00:57:48.380 and like production of lactic acid, not looking at what Warburg actually looked at, then you have
00:57:52.840 a very different explanation for what's happening. So, a lot of people today look at, use the seahorse
00:57:58.660 instrument to measure oxygen consumption. And when you put cancer cells and tumor cells,
00:58:03.760 normal cells into a dish, they're all taking up oxygen similarly. And therefore, Warburg must be
00:58:08.600 wrong. Warburg also said that tumor cells and normal cells will take, some will take up oxygen at the
00:58:14.720 same rate. Except the tumor cell is uncoupled and the normal cell is not uncoupled, which means that
00:58:19.400 the oxygen uptake in the tumor cell is not linked directly to ATP production. People ignore that.
00:58:25.340 So, they just don't. And some of the most beautiful experiments-
00:58:27.920 How would one measure that? ATP is very tricky to measure, ATP production.
00:58:32.360 No, ATP can be measured. The problem is, is that what's the origin of it?
00:58:37.000 Well, that's what I mean. Isolating. So, let's say you have a tumor cell and a non-tumor cell,
00:58:41.940 and they're both taking up lots of oxygen as measured by, you know, calorimetry. And one's
00:58:47.680 producing a bunch of lactate. But how can you tell if the cancer cell is taking up oxygen and
00:58:54.360 not making ATP? Well, if it's taking up oxygen, well, if it doesn't make ATP, it's dead. All right,
00:59:00.880 so- Sorry, if it's not making ATP commensurate with its oxygen consumption.
00:59:05.980 Well, sometimes you look at that and you'd say, well, look at the oxygen consumption is,
00:59:09.500 the ATP production is commensurate with oxygen update.
00:59:12.700 Yes.
00:59:13.160 Okay.
00:59:13.880 That would be coupled, wouldn't it?
00:59:15.760 Well, as long as it's not producing lactic acid or succinic acid. Okay.
00:59:19.600 So, I'm a bit confused. Why couldn't it do both? Couldn't a cell undergo anaerobic metabolism,
00:59:26.200 make ATP that is accounted for by the amount of lactate that's produced, but similarly take up
00:59:31.720 oxygen and in a coupled fashion make ATP there?
00:59:34.820 That's an important point because a lot of people stumble on that. The problem with that is that
00:59:40.280 when you're looking at the ATP production coming out of the mitochondria, it's not always easy to
00:59:46.760 know whether it's from a coupled, generated by a coupled mechanism where the oxygen is in fact
00:59:53.480 linked to the ATP through F1, F0 ATPase, or whether it's coming from mitochondrial substrate level
00:59:59.960 phosphorylation.
01:00:01.380 Ah, got it.
01:00:02.420 So, you can't, there's not, it's not easy to do the mass balance of this many moles of oxygen were
01:00:07.340 produced or consumed and this many moles of ATP were produced. You can't do that math.
01:00:13.860 Well, Warburg did that, but he was looking at-
01:00:16.080 But he didn't know about SLP, right?
01:00:17.940 Well, lactic acid production, the production of ATP at the pyruvate kinase is substrate level
01:00:24.060 phosphorylation, but it's cytoplasmic.
01:00:26.180 Yes, yes. It's not mitochondrial.
01:00:27.860 He did not know, he couldn't have known because the very systems that were, they didn't come out
01:00:32.980 until the 50s, 60s, that we knew that there was another form of ATP production inside the
01:00:38.160 mitochondria. What people have failed to realize is that they consider, every biochemical textbook
01:00:46.200 says we only get 2% oxygen coming out of the mitochondria through a substrate level
01:00:51.000 phosphorylation, just like we get from the cytoplasm. But for cancer cells, people say, oh,
01:00:56.800 you can get a lot more ATP from the cytoplasm. But not thinking you can upregulate the same
01:01:01.580 phenomenon inside the mitochondria. As a matter of fact, we think that substrate level phosphorylation
01:01:07.100 in the mitochondria is far greater than the amount of ATP produced in the cytoplasm. And that's because
01:01:13.560 others can't, and others, a number of people have found that the PKM2 isoform of pyruvate kinase
01:01:19.480 doesn't make much ATP. It makes a buttload of lactic acid, but it's not linked to the ATP
01:01:24.720 production. So therefore, they have to say respiration is normal because the cell is making
01:01:29.120 so much ATP. But if Otto Warburg is correct, and all of the structural biochemistry is correct,
01:01:36.340 the mitochondria can't be making oxygen from oxidative phosphor. It can't be making ATP from
01:01:40.460 oxphosphor. It can't be because the structure of the organelle is defective. So where the hell is
01:01:45.580 all that damn ATP coming from inside that organelle? And then when you look at the data that we have,
01:01:52.100 and glutamine is being consumed in massive amounts. So it's got to be coming from substrate level
01:01:57.940 phosphorylation. What is the fundamental structural defect in the mitochondria? Which is interesting.
01:02:02.200 I'd never thought until this discussion about the possibility that you could have a completely
01:02:07.820 normal mitochondrial genome and just have structural defects. And then of course, obviously you can have
01:02:13.520 genetic abnormalities that lead to protein productions. They create structural problems.
01:02:17.880 But in the case of the former, perfectly normal genome.
01:02:22.100 Mitochondrial DNA genome.
01:02:23.380 That's right. Mitochondrial.
01:02:24.560 Yeah.
01:02:25.000 But you now have a defective. What is the actual physical defect?
01:02:29.120 In the structure, the number structure. This is the, it can happen in many different ways.
01:02:33.800 For example, if a carcinogen enters into the mitochondria, they cause a lot of oxidative stress.
01:02:40.220 And what we found in our massive studies, this is how we got onto the mitochondria, knowing that
01:02:45.760 Otto Warburg was in fact correct. I mean, at first I was, didn't know what the hell was going on like
01:02:49.980 anybody, like everybody else. But when we found no mutations in the mitochondrial DNA, and we knew
01:02:56.380 these cells were fermenting because they were making a lot of lactic acid. Then we started looking at the
01:03:01.320 lipids inside the mitochondrial lipidome. We call it the lipidome. And we have found that cardiolipin,
01:03:08.860 the signature lipid in the inner membrane is defective in all the tumor cells that we've
01:03:12.720 ever looked at. So that tells us right there that there's a problem in the function. And then we
01:03:17.260 link that to abnormalities in Oxfos. So clearly lipids are abnormal. That would affect the function
01:03:23.880 of the proteins of the electron transport chain. Therefore, you're not going to generate the
01:03:28.680 amount of ATP through oxidative phosphorylation because the very lipid and protein structures are
01:03:36.320 abnormal. And you can't produce the amount of ATP. So that supports Warburg knew that there were many
01:03:43.920 problems in the mitochondrial function that would then force the cell into fermentation.
01:03:48.820 So what did they ferment? They ferment lactic acid and succinic acid. What are the fuels for that?
01:03:55.460 It's glucose and glutamine. So glucose and glutamine are ultimately the fuels that drive the cancer.
01:04:00.420 And they drive it through a process of substrate level phosphorylation occurring in the cytoplasm
01:04:05.880 where they can build a lot of metabolites for growth and also through the pathway called
01:04:10.460 glutaminolysis. Now, one can't render glucose zero, meaning there's no dietary or pharmacologic
01:04:18.800 intervention that could reduce glucose levels to zero. Are there any that could do that with glutamine?
01:04:24.580 Or is it similar? Let me address the glucose issue. We can't get to zero,
01:04:28.660 but we can get damn close to it. All right? So we have people, published papers,
01:04:34.140 people who have gone powerful therapeutic fasting only, and then given large injections of insulin.
01:04:39.240 Sure. And they've got to below one millimolar.
01:04:41.060 Yeah, 0.5.
01:04:43.160 But sustainably, it's very difficult to be below about three millimolar, right?
01:04:47.620 Right, right. But here's the situation. The problem is, is when you do that,
01:04:51.400 you go into calorie restriction, restricted ketogenic diets,
01:04:54.000 you already are lowering the blood sugar to a significant degree. And what we found is that
01:04:59.420 glucose transporters actually get upregulated in the normal cells when you start doing this.
01:05:04.300 So the normal cells become glucose hungry. And they become direct competitors now with the
01:05:09.200 tumor cell that absolutely needs the glucose, because the normal cells can burn the ketones and
01:05:13.100 stay alive. The tumor cells can't burn the ketones because they're mitochondria defective.
01:05:17.380 So you need a good mitochondrial system to burn ketones for energy. So what we do by calorie
01:05:22.860 restriction and keep restricted ketogenic diets is we make the normal cells glucose hungry,
01:05:27.680 and we transition them over to ketones, keep them alive, but they're still glucose hungry.
01:05:32.860 And they are now competing directly with the tumor cells that absolutely have to have the glucose.
01:05:37.520 It's interesting because clinically, we don't see that, right? So clinically, when we put
01:05:40.800 most people on a ketogenic diet, or a calorie restricted diet, in the short run,
01:05:46.140 they actually become physiologically quite insulin resistant. Meaning when you challenge them with
01:05:51.900 glucose, they have a paradoxical rise in glucose and insulin that's overcome by refeeding them with
01:05:58.140 carbohydrates for three or four days prior to the glucose challenge. And the offered explanation is
01:06:04.300 that during a period of starvation and or carbohydrate restriction, the muscles, which are obviously the
01:06:10.260 dominant sink for glucose, basically become resistant to insulin, not in a pathologic way,
01:06:18.300 but rather in a way to allow the brain to have access for the remaining glucose.
01:06:22.820 Well, if you do it in acute systems like that, rather than the chronic changes that we talk about,
01:06:27.460 you can get those kinds of an effect. Generally, calorie restriction makes the body super insulin
01:06:33.700 sensitive.
01:06:34.120 Yeah, it's interesting. This is something I've struggled with because I was on a ketogenic diet
01:06:39.260 for three years. And at the end of that period of time, I went up to Stanford and did an insulin
01:06:45.940 suppression test, which is, along with the euglycemic clamp, really the gold standard for
01:06:50.440 measuring insulin sensitivity with Gerald Riven, the late Gerald Riven. And Jerry was just interested
01:06:56.400 in my physiology. It was like, wow, you're kind of a weird guy. You're on this bizarre ketogenic diet.
01:07:01.240 Hadn't studied it. He did at the time have a publication of about 400 non-diabetic subjects
01:07:09.760 who he had put through the insulin suppression test. The way this test works for the listener
01:07:13.600 is you take an individual, you hook them up to two intravenous lines, one that puts glucose in,
01:07:19.500 one that puts insulin in. And over a six hour period of time, you follow a protocol of injecting
01:07:26.060 glucose and insulin. And after about six hours, the glucose level reaches a steady state level
01:07:32.080 referred to as the SSP or steady state plasma glucose level. And the higher that is, the more
01:07:38.420 insulin resistant you are said to be, the worse you are at glucose disposal. The lower that is,
01:07:43.960 the more efficient you are able to dispose of glucose. So, and that number, the SSPG correlates to
01:07:50.180 the one over the M value, which is the Y-axis intercept on the U-glycemic clamp. So anyway,
01:07:56.640 so I went to Stanford one day.
01:07:58.200 Well, let me, let me, why, why would you inject glucose and insulin? If you were on a ketogenic
01:08:02.920 diet, you'd be already, and you were to take glucose, your insulin levels would already go up
01:08:07.660 to the maximum physiological. So you're actually giving too much insulin in a situation like that.
01:08:12.120 Well, so this was part of the issue, right? We didn't know what to do because the protocol is
01:08:16.480 all developed around people, not on a ketogenic diet. These are all people eating a standard diet.
01:08:21.460 But what you've, what you're alluding to is what we discovered very quickly. So again,
01:08:25.120 this is supposed to be a six hour test. And when you looked at, and I looked at the data before we
01:08:30.580 did this to get a sense of what the parameters were of the 400 non-diabetics that they had done this on
01:08:37.280 the most insulin sensitive person ended up having an SSPG of about 79 milligrams per deciliter,
01:08:45.320 meaning the lowest that anyone's glucose got following this protocol was 79 milligrams per
01:08:51.700 deciliter, which perfectly reasonable. And the highest was, I don't recall this, but we could
01:08:58.220 look up the paper, but I think it was somewhere in the vicinity of 200, 300 milligrams per deciliter.
01:09:03.140 So that's a person who is functionally a diabetic. And even though they're quote unquote, you know,
01:09:08.140 normal, their A1C was less than 6.5. They're very soon to be a diabetic. And of course,
01:09:12.140 when you do this on people with type two diabetes, they're all very, very high.
01:09:15.920 So we're doing this test where they're sampling glucose levels every 30 minutes. And within an
01:09:21.740 hour, meaning after just the first, second, third sample, it was clear my glucose was going down
01:09:27.540 very quickly. So they said, okay, we're going to back off on the insulin to your point at 90 minutes.
01:09:34.580 And I have to go back and look, cause I have all the data. I could be wrong. Maybe it was a little
01:09:38.040 longer than that. I think it was about 90 minutes. They basically turned the insulin off. Now at this
01:09:42.140 point, my ketone started to go down. I think between the 90 minute and the two hour mark,
01:09:48.700 it got really bad, really quick. And my ketones at this point had gone from, I don't remember,
01:09:54.360 somewhere between two and a half, maybe three millimolar down to less than one millimolar.
01:09:59.160 And they said, you know, we're going to stop the test now because your glucose is in the
01:10:04.780 forties. I believe I was at about 48. Yeah. No ketones. You're going to go
01:10:08.540 unconscious. You've got to be careful. Yeah. So in the end, I almost did go unconscious. And
01:10:12.880 the last thing I sort of remember was the profound perspiration that came over me, which is very
01:10:19.880 different from the perspiration you experienced like on a day like today in Boston, where it's hot
01:10:24.040 and you're sweaty. It's, it's not that type of a perspiration at all. It felt like I was in a shower
01:10:29.360 and I began shaking and probably was about to have a seizure. And then they went. So the last
01:10:36.860 blood glucose, I think they, I, they got on me was about 31 milligrams per deciliter. And when they
01:10:41.880 were injecting the dextrose, the D50, I was conscious enough to realize the IV had infiltrated.
01:10:48.660 So all I felt was the most ridiculous burning sensation in my antecubital fossa, because I
01:10:54.120 realized the dextrose was not getting into my... Why you put yourself in situations?
01:10:57.600 I'm an idiot. I mean, the worst part of that story is I didn't, I would never do any of that
01:11:01.520 stuff. When I came back to life, I, uh, I had a huge, huge infiltrated IV in my right, in my left
01:11:09.580 antecube. I took a picture of it and I sent it to my wife and who I didn't even tell that I had
01:11:14.460 flown up to San Francisco that day. I think I was just like, you know, I travel so much that like
01:11:18.040 I could be gone for a day. She wouldn't even know it. And I was like, Hey, check this out. And she's
01:11:21.940 like, where are you? And I was like, Oh, I'm up at Stanford today doing such and such. She's like,
01:11:24.860 what? You just about died. And like, you gotta, you gotta, if you're going to die, I mean,
01:11:30.240 you're an idiot, but you've got to tell me in advance where you're going to be when you die.
01:11:33.720 Yeah. Well, I mean, our goal is, is not to try to kill ourselves. It's just kill the tumor
01:11:38.220 cells and make the rest of it. Okay. So my long winded story there was to illustrate a point.
01:11:42.160 I turn out to be an exception to that rule. So, and I did this with oral glucose tolerance tests as
01:11:48.100 well. And I never had that physiologic insulin resistance. In other words, I seem to be one of the
01:11:52.380 people for whom what you're saying seems to be correct chronically, which is whenever I'm on a
01:11:57.480 ketogenic diet, my glucose disposal is remarkable, but now putting on my sort of your insulin set,
01:12:04.640 you're very high insulin. My muscles become very insulin sensitive, but without the refeeding of
01:12:11.420 carb. Yeah. Yeah. What I noticed though, is clinically, I see so many patients for whom that
01:12:16.340 is not the case. If I do an OGTT, an oral glucose tolerance test on a patient in a ketogenic diet,
01:12:22.860 I feel like, and again, I think other physicians listening to this will have to weigh in with their
01:12:27.580 opinions. I feel like 70% of them fail the OGTTs and look like they have diabetes or are, or very
01:12:35.260 soon to. However, if when on the repeat OGTT, you just say, look for the three days prior to the test,
01:12:41.780 you're going to eat two potatoes a day. They pass with flying colors. In other words,
01:12:46.460 they show that they are indeed very insulin sensitive, but they need to be primed a little
01:12:50.920 bit. So my point though, is if that's the case, if the 70% of patients or whatever the number is,
01:12:57.380 they wouldn't actually benefit from this effect, right? Because they'd be walking around and not,
01:13:04.340 you know, they'd be, the muscles would be selectively not consuming that glucose.
01:13:07.780 Unless you can get the blood sugar down. Like, as I said, we're, we're experimenting now. Because
01:13:12.780 don't forget, our goal is to starve the tumor cells. This, I mean, we're singularly focused on
01:13:17.560 this. The issue here is how you starve the fermentable fuels without causing-
01:13:23.140 Without starving the normal cell.
01:13:24.360 Yeah. And, or harming at all. It sounds to me like you were brutalized in that experiment.
01:13:28.400 Well, yeah, yeah. That's a not to be done at home.
01:13:31.100 That's not what our goal is here. Our goal is to emerge from the therapy healthier than when you
01:13:35.380 start it. So the question becomes, how low can you get blood sugar without compromising
01:13:40.200 the health status of the individual? And again, if you're in ketosis, you can push your blood sugars
01:13:46.360 down really low.
01:13:47.620 But you'd want to do this without insulin because insulin itself is pro-tumorogenic.
01:13:52.180 Only if the blood sugars are high enough. Once you get those blood sugars down and you take away all
01:13:56.740 the glucose from the body or the majority of it, it kills the tumor cells. We have the data to
01:14:01.060 support that.
01:14:01.560 Insulin per se is killing the tumor cell or the reduction of glucose?
01:14:05.840 The reduction of glucose.
01:14:07.260 Even, so you're saying basically-
01:14:08.820 Because you can't eat insulin.
01:14:10.040 Insulin doesn't give you ATP.
01:14:11.860 So, but you're saying insulin does not function as a growth signal outside of its anabolic activity
01:14:19.180 and taking up glucose?
01:14:20.320 Well, if you have high, like insulin, like growth factor, of course, is linked to the insulin,
01:14:24.360 of course, that facilitates the uptake of glucose. I mean, if you don't have glucose,
01:14:28.040 if you don't have glucose, what doesn't make any difference? What else is going on? Because
01:14:31.500 without ATP, you can't get energy anyway. So, the goal is to take, deplete the sources of fuel
01:14:37.220 to the cells. So, insulin, you can't eat insulin. Now, insulin drives the pyruvate dehydrogenase
01:14:42.780 complex, which facilitates, that's why they say, oh, you know, you can get this and that.
01:14:46.900 That's only if you have a lot of glucose around. Insulin becomes pro-tumorogenic.
01:14:50.960 But if you have very little glucose and you give more insulin, remove the, it doesn't stimulate
01:14:54.640 tumor growth. We have direct evidence to support that. So, in fact, the Germans used to do that.
01:14:59.640 They used to put people into insulin comas. The problem is you don't want anybody going to an
01:15:03.880 insulin coma. If they were in ketosis, you could give a shitload of insulin and you're not going
01:15:07.880 to die. We have evidence in the literature to support that. So, you got to keep the door shut
01:15:13.540 on that insulin or on the glucose as tight as you can without harming the rest of the body.
01:15:18.940 So, we use insulin and then we do hyperbaric chambers, but that comes only after you shut the door
01:15:24.040 on the insulin and the glutamine. So, if you-
01:15:26.460 So, how do you shut the door on glutamine?
01:15:27.600 The glutamine door, you have to use drugs. And the best drug we've found so far is
01:15:31.040 don6-diasin, norleucine. It's an old drug, was made years ago. They used to use it on cancer
01:15:38.760 patients, but they never targeted glucose at the same time. So, the tumor cells were sucking
01:15:43.120 down the glucose. As a matter of fact, you can even make the more glucose sensitive if you take
01:15:47.580 away the glutamine.
01:15:48.020 So, there's no dietary strategy that could effectively reduce glutamine?
01:15:51.480 No. Glutamine is a non-essential amino acid. We can make glutamine from glucose. I mean,
01:15:57.100 so, it's why it's called non-essential. However, in physiology terms, it is essential. It plays a
01:16:02.200 massive role in the gut, in the immune system, in the urea cycle. I mean, it's such an important
01:16:08.140 amino acid and it's ubiquitous. It's the most abundant amino acid in our body.
01:16:11.980 Yeah. That's a funny distinction. I'm glad you pointed that out for this is a total aside,
01:16:16.040 but I'm sure that there are people listening to this who get confused by the term essential and
01:16:19.620 non-essential because it's eight of them are essential and 12 are non-essential or something
01:16:22.820 to that effect. But what you're pointing out is an important distinction. They're non-essential
01:16:27.340 because we don't have to get them exogenously. They're still essential for our survival once
01:16:33.320 produced endogenously.
01:16:34.860 Yes, absolutely. And glutamine, if you look, it's the most abundant amino acid in our serum. It's
01:16:39.740 everywhere. And our immune system-
01:16:41.380 So, the point being, there's nothing you're going to eat or not eat that's going to change that.
01:16:44.440 People ask me that all the time. It's got to be drug. You got to do it drugged. And you have to
01:16:48.480 use drugs, but it has to be done strategically. And you have to have people that are knowledgeable
01:16:52.360 about this. You can't just have some guy just jack you up with a drug that blocks glutamine
01:16:56.440 because it has to be because your immune systems will be compromised. And our immune system is needed
01:17:02.400 for the health of our gut, the health of killing bacteria. And if you use, if you paralyze them too
01:17:07.520 much, then you're going to get infections. You're going to have all kinds of other issues.
01:17:10.640 So, that's why we developed the press pulse concept. So, you press the glucose hard with
01:17:16.560 diets and drugs, and then you pulse the glutamine. So, what we think is going to happen is we will
01:17:21.980 target the glutamine with a drug that will selectively kill tumor cells, paralyze the
01:17:26.900 immune system, but then immediately give large amounts of glutamine back. And the issue, of course,
01:17:32.140 is that you're going to restore your gut and you're going to restore your immune system because
01:17:35.280 they're only paralyzed. They're not killed.
01:17:36.660 And when you say immune system, are you referring to the cellular or humeral system?
01:17:41.900 The cellular, mostly the cellular.
01:17:42.660 Because you've implicated, we're going to come back to it, but you've kind of implicated the
01:17:46.100 humeral system with the macrophage in terms of mutagenesis.
01:17:49.980 Well, we're talking about the cellular immune system.
01:17:53.560 Yeah, you're talking about the T cells.
01:17:54.700 And B cells and macrophages and natural killer cells, leukocytes, all these kinds of things.
01:18:00.460 They're all glutamine dependent. They're all heavily glutamine dependent. Okay. So, if you have a
01:18:04.740 patient that's burned the skin, now you're opened up to bacteria, you have to give large amounts of
01:18:10.000 glutamine because the immune system is needed to kill the bacteria. You have to restore the gut
01:18:15.440 function. A lot of the cells in the gut are glutamine dependent. So, that's why you give large
01:18:21.160 amounts of glutamine to cancer patients that have been subjected. But the problem is, of course,
01:18:26.260 is the tumor cells are using the same fuel. So, you have to know. And as I said, if you kill too
01:18:32.420 many of the tumor cells too quickly, you've got to have a cell system to remove the corpses.
01:18:37.020 You've got to have some, and that's what the macrophages do and some of these other immune
01:18:41.240 cells. They'll come in and remove the dead cells. Otherwise, you get infections. You die from the
01:18:45.700 indirect effects of these things. So, you have to know how to strategically target glutamine without
01:18:50.820 compromising the normal physiological systems that we have.
01:18:54.780 So, before we get into the therapeutic stuff, which I understand is probably what everybody wants
01:18:58.080 to hear about. I still want to get back to kind of understanding some of this stuff a little bit
01:19:01.400 better. So, experimentally, I'm still struggling with this sort of chasm in belief systems between
01:19:08.700 what sounds like the majority of people who take the view that says, look, the respiratory system of
01:19:14.840 the cancer cell is relatively normal. If you're seeing an increase in fermentation, it's an artifact of
01:19:21.460 a higher throughput of substrate to generate more building blocks. This strikes me as a very testable
01:19:26.340 hypothesis. This really shouldn't be, we shouldn't be debating this. There should be a set of
01:19:30.340 experiments that could resolve that, correct?
01:19:32.040 Well, yeah. And I think that diagram there on the board is the illustration of the strategy to
01:19:38.320 test that hypothesis, basically, which is where are they getting their energy from? The bottom line is
01:19:43.280 where are they getting their energy from? If you stop their energy-
01:19:45.740 The board picture, by the way, we're looking at everything. We're looking at the, we'll put a picture
01:19:49.520 of this, of course, up there, but it's basically the TCA along with everything outside of the TCA as
01:19:55.400 well. It's effectively looking like, it's even metabolic pathways that I can't name at this
01:20:00.080 moment.
01:20:00.340 Yeah. It's because you have to try to integrate, like you said, you have to try to integrate all
01:20:04.400 of the knowledge that we have on the biochemical systems into a strategy to manage the disease.
01:20:09.020 And I break it down into more simplistic things. In other words, energy. Without energy, nothing
01:20:14.740 grows. And the evidence that I'm convinced about, that I've read massive amounts of literature and
01:20:21.000 looked carefully at everything, the structure and function of the mitochondria in tumor cells
01:20:25.840 is compromised. All right. That's a fact. That's, in my mind, that is a solid fact. And to deny that,
01:20:31.960 one would have to ignore the evidence that I've looked at. You have to look at a mitochondria and
01:20:37.340 say, no, that mitochondria that has no cristae and is very few in number, there's nothing wrong with it.
01:20:42.900 Okay. Let's call it white, black, and black, white. I mean-
01:20:46.560 But let's go one step further because there's an objective way to assess structure. But shouldn't
01:20:54.140 we just ask the functional question?
01:20:56.100 Well, as I said-
01:20:56.860 Experimentally, I mean.
01:20:57.660 Yeah, of course. And we do that. So we know structure dictates function. That's a common
01:21:03.400 in biology. Then if that structure looks abnormal at the electron microscopy level, at the various
01:21:08.880 levels, why don't we look now at the activity of the proteins in the electron transport chain?
01:21:14.440 And just as an, this may be a naive question, but there can be large ranges of structure that
01:21:21.300 could still produce optimal function. And you would think that for something as important as
01:21:26.100 respiration, which to your point might be the single most important function of a cell as
01:21:32.000 evidenced by the fact that toxins like cyanide are uniformly fatal within seconds, you'd think
01:21:37.320 that the structural leeway within a mitochondria would be so high that you could, let's just
01:21:44.520 say you could quantify structure as a scale from one to 10. And obviously a 10 out of 10
01:21:50.400 structure is perfectly functional. You'd want to believe that that thing would function good
01:21:55.440 enough down to like a two out of 10. And only if you were staggeringly compromised, does everything
01:22:00.880 go to hell? So in other words, just to push back for a moment, one could argue, hey, yeah, of course
01:22:06.040 there's structural changes, but they're not functionally relevant because they're within a
01:22:10.780 parameter space.
01:22:12.020 Yeah, no, that's an important point. And I think the normal flexibility of our cells-
01:22:16.100 Yeah, that's the better word. It's the flexibility.
01:22:17.780 Yeah, the normal flexibility is able to accommodate those kinds of changes over the short period of time.
01:22:23.300 Mitochondria is such an incredibly vibrant system. It's a living organelle inside of
01:22:28.760 our cells, right? It's a separate organism actually.
01:22:31.680 Separate DNA.
01:22:32.520 Yeah. And they've turned over all of their DNA to the nucleus except for 13 critical genes. And
01:22:39.720 those 13 critical genes control the life of the cell. And so why should I do this activity when I
01:22:47.260 can get a dumbass nucleus to do it for me? But I'm still going to hold the keys to the kingdom.
01:22:51.820 There's still 13 genes that if anything goes wrong with them, you're dead. And this is the
01:22:56.480 whole thing, why cancer cells don't die through the apoptotic mechanism. Because the very organelle
01:23:00.740 that controls the kill switch, the switch doesn't work. So the cell bypasses the normal control of
01:23:08.180 life apoptosis in the cell because the very organelle that dictates that is now defective.
01:23:14.460 So consequently, this cell now is reverting back to the way it existed before oxygen came into the
01:23:19.720 atmosphere on the planet. They were all fermenters. They grew with unbridled proliferation until the
01:23:25.220 fermentable fuel in the environment disappeared and they all died. So it was very clear what was
01:23:31.060 going on before oxygen came into the atmosphere. Cells would proliferate unbridled. Albert St.
01:23:36.780 Georgi, there's alpha period in the existence of the planet. So everything was working on substrate
01:23:41.000 level phosphorylation. It was no oxidative phosphorylation. They're all doing that.
01:23:44.740 What we have in our system today is these same capabilities, but we don't use them,
01:23:51.160 but only for very short periods of time under very various physiological stress situations.
01:23:57.020 They don't become permanent. In the cancer cell, they have become adapted because as Warburg said,
01:24:03.300 you can't get a cancer cell from a cell that cannot ferment. So neurons in the brain can't ferment for
01:24:08.500 very long. You rarely if ever get a tumor out of a neuron, except neuroblastoma, which is outside the
01:24:13.760 brain. So heart cardiac myocytes rarely form cancers. Even muscle cells rarely form because
01:24:19.240 you have the sheets and stuff. So cells that need a lot of oxidative phosphorylation rarely can form
01:24:24.320 a tumor. Only tumors can form in those cells that can upregulate fermentation pathways. If you can't
01:24:29.520 do that, you're going to die. But wait, wouldn't skeletal muscle be one of the highest candidates to
01:24:34.220 be able to upregulate fermentation given their ATP demand? Yes, but they have a syncytium of mitochondria
01:24:39.580 inside the muscles and they've adapted. This is their part of the normal physiology. They can
01:24:43.740 ferment for periods of time under extreme stressful conditions. They can't permanently do that. They
01:24:48.880 die. The muscles will die on you. The cells will die if you try to force them into a long-term
01:24:53.960 fermentation metabolism. But they have the capacity to upregulate fermentation for short periods of
01:25:00.420 time, like many cells do. But brain can't do that. Heart can. You're going to have a heart attack.
01:25:04.700 Let's go back to the, this is an interesting point you bring up. Let's go back to a myocyte
01:25:09.900 within my quadricep versus a epithelial cell in my colon. To your point, the probability I will
01:25:18.740 get a cancer that comes from the myocyte in my quadricep is virtually zero.
01:25:23.680 No, I didn't say virtually zero.
01:25:25.180 But it's, I mean, outside of a sarcoma.
01:25:27.640 Sarcoma is, well, you know, what is a sarcoma? What's the origin of the sarcoma? What kind of
01:25:31.560 cell? It depends. It can be a myoliosar coming. There can be many. But just humor me for a moment.
01:25:36.020 Probability-wise, the myocyte in my quadricep or my pecs or something forming cancer is so much lower
01:25:42.680 than the epithelial cell in my colon, right?
01:25:45.120 Yeah. Or an epithelial cell in your kidney or your bladder or one of these kinds of things.
01:25:49.000 I just pick colon because it's such a high cancer probability.
01:25:51.500 Right, sure. Breast is another one.
01:25:52.960 Yeah, yeah, right. So what is it, explain to me again the difference in their, because I would say
01:25:59.600 like the muscle cell is far more adaptable at making lactate when it needs to, because it's,
01:26:05.380 I demand of it much more than I demand of my colonic epithelial cell. But then say what you
01:26:09.620 were saying again about the toxicity of lactate to that cell versus the epithelial cell in my colon.
01:26:13.740 Well, the epithelial cell in your colon, if it becomes, and again, it's a longer process,
01:26:19.600 you know, it's not something, you don't go from a normal cell to a cancer cell overnight in a colon.
01:26:25.260 There are some situations where cancer can happen much quicker than people would normally think,
01:26:31.020 but in general, it's like it's a protracted process. So the cell has to have the capacity
01:26:36.780 to shift from an oxidative process to a fermentation process. You have to have the
01:26:43.620 machinery in the cell to be a fermenter, because without that capacity, you can never become a tumor
01:26:49.180 cell. Because the cancer is twofold process. One is the gradual chronic interruption in respiratory
01:26:57.140 function, coupled with a gradual compensatory shift to the alternative form of energy, which is
01:27:06.380 substrate level phosphorylation. So if the cell is incapable of making that shift, it will never
01:27:12.940 become a cancer cell. It can't, because in order to be a cancer cell, you have to be able to replace
01:27:18.140 oxphos with fermentation. And if you can't do that, you're not going to become a cancer cell.
01:27:23.320 And that's why brain neurons rarely become tumor cells, because they can't do that. Brain cells die.
01:27:29.500 So if you interrupt oxidative phosphorylation in the neurons of our brain, we call that
01:27:34.800 neurodegeneration. So we don't generally get tumors. We get tumors from the glial cells and the
01:27:39.740 microglia and these kinds of things.
01:27:41.300 Yeah, this isn't important. I mean, I know what you're saying, but I know the listener will be
01:27:44.300 confused by this because they're going to say, but gosh, my aunt had brain cancer.
01:27:47.480 It's very important that we distinguish between the glial cells and the neurons.
01:27:51.480 And the microglia, there's another form of which we think are neoplastic.
01:27:54.300 But when we hear about astrocytomas, which would be the most common brain tumors,
01:27:58.520 they're not actually, the cancer is not existing in the neuron.
01:28:02.500 That's correct. They're not neurons. So these are the kinds, or cardiomyocytes.
01:28:06.500 You generally, because you're going to, you know, they just, they die. These, because you're
01:28:09.840 packed with mitochondria and you start, they start fermenting. You can't, they die. They can't deal with
01:28:14.480 that. Again, see, that's the part, Tom, that just confuses me. It's so counterintuitive.
01:28:18.300 I would think that if there's going to be a cell in my body that I want to be able to buffer lactate
01:28:24.000 and specifically buffer the hydrogen ion that comes with it, that's actually what's killing the cell.
01:28:28.800 I would want my cardiac myocyte to be the single most robust cell in the body because it has to be
01:28:34.240 the last guy standing.
01:28:35.520 Yeah. Well, you know, this is the whole thing. When you get a, when you get a heart attack,
01:28:38.660 you die from brain damage. You don't die from, your liver and kidneys are fine. That's why you can
01:28:42.400 donate your liver and kidneys when you have a heart attack because those cells are not dying
01:28:45.980 because they have the, they have the brain is most susceptible to the hypoxia. But the point is,
01:28:49.740 even at the level of the highest stress, I would want my cardiac myocytes to be able to access all
01:28:56.880 fuels, glucose, fatty acid, ketone, you name it.
01:29:00.440 They do that with heart, degenerative heart disease, but they don't form cancer. They have a
01:29:05.520 capacity. And this is where we found a lot of substrate level phosphorylation in the mitochondria,
01:29:10.380 the TCA cycle was discovered in stressed hearts. Okay. So, because they were saying,
01:29:16.340 well, the heart should be dead, right? I mean, why is it still functioning here? Where's the ATP
01:29:20.140 coming from? And they found that the way most of the energy in the heart is coming from mitochondrial
01:29:24.700 substrate level for shorter periods of time. I'm not saying this is a, you can't do this as a
01:29:28.720 permanent shift, but the concepts were developed from the word, the work in the heart, but you would
01:29:33.580 expect. Yeah. Well, same with my brain. I mean, why that, I mean, if your brain damage,
01:29:37.740 you can't function either. I mean, so the two organs, heart and brain are remarkably dependent
01:29:44.860 on oxidative phosphorylation for function and disruptions of oxidative phosphorylation are
01:29:50.020 usually catastrophic for those cells. I mean, of course, after time. I think I understand your
01:29:54.480 argument. What's your, I was thinking about it in reverse. You're saying because the brain and the
01:29:59.000 cardiac myocyte have evolved to be so efficient under oxidative conditions, it's not so much that
01:30:05.620 lactate is harmful to them. It's that once you start to disrupt, if the hypothesis is correct,
01:30:12.560 that it's the disruption in the mitochondria and its capacity to carry out oxfos that's harmful,
01:30:19.960 you die long before you get bother getting cancer. Those cells get, undergo apoptosis or just die.
01:30:25.660 I understand your point.
01:30:26.780 Yes. That's the point. That's the point. So, so the key is that how long does it take to
01:30:31.300 transition a cell from an oxidative phosphorylated state in a cell that can become a tumor like a
01:30:35.820 colon, as you mentioned?
01:30:36.580 So the real problem that these other cells have where cancer is so ubiquitous, whether it be breast
01:30:41.020 or colon, according to this hypothesis, would be their metabolic flexibility. It's their capacity to
01:30:46.920 easily wax and wane between, I shouldn't say that. It's not their flexibility. It's their lack
01:30:53.160 of dependency on oxidative phosphorylation.
01:30:55.100 Well, they depend. I mean, obviously, like you said, with cyanide, I mean, it shuts down. Everything's
01:30:59.680 dead real quick.
01:31:00.440 But that happens so quickly that they don't have the ebb and flow.
01:31:03.180 It's their capacity to upregulate fermentation over time because it doesn't happen overnight. It's a
01:31:10.580 very gradual thing. And heart cardiomyocytes and neurons of the brain can't do that, that these
01:31:16.580 other cells are capable of doing. And as I said, what happens is the, again, you had that
01:31:21.920 mitochondrial stress response. And this is where your oncogenes come in now because the
01:31:27.400 oncogenes are transcription factors that upregulate fermentation pathways. So basically, when you
01:31:34.100 damage the respiratory system of a cell, HIF-1-alpha becomes stabilized. And now you can upregulate
01:31:42.360 glucose transporters into the cell. Myc is a glutamine. They all overlap each other. Lactic acid,
01:31:48.700 the dehydrogenase, you know, all these enzymes that are geared for maintaining a fermentation
01:31:53.900 metabolism, the transcription factors that make those pathways upregulated are the oncogenes,
01:32:00.140 basically. So the oncogenes have to facilitate. If you're not going to get the same level of energy
01:32:05.940 out of your oxfos, you've got to compensate to get, because as I tell everybody, the singular most
01:32:12.120 largest consumer of energy in any cell is the pumps. These pumps that are on the surface of
01:32:18.640 the cells that maintain the ionic gradients that allow what we call life. Because once you reach
01:32:24.340 equilibrium, you're dead. So most of the energy in any cell, cancer cell, heart cell, and it's the
01:32:30.600 proton motive gradient across the membrane that determines whether or not that cell is going to be
01:32:35.760 alive or not. So you need ATP for that. If the ATP dissipates, you swell and die. You undergo apoptosis
01:32:42.880 or whatever. So you have to then determine, you know, where's my ATP coming from? How am I going to
01:32:48.040 keep those pumps going? And if fermentation becomes a replacement, therefore I'm going to need a lot of
01:32:54.280 extra fermentable fuels to make up the loss of the energy that I'm getting out of oxfos.
01:33:00.480 So oncogenes have to turn on because they are the transcription factors that upregulate the
01:33:05.320 transporters for glucose and glutamine. So you're bringing in two alternative fuels to make up the
01:33:11.080 difference. And therefore the genetic behavior of the cell begins to change. And then because the cell
01:33:17.080 is now using damaged respiration, you throw out a lot of reactive oxygen species from the damaged
01:33:22.860 respiratory system. And they cause, they're mutagenic and carcinogenic. So the nuclear genome
01:33:28.780 gradually collects all these different mutations and defects coming from the ROS of the mitochondria.
01:33:34.040 But at the same time, the cell is not dying from this ROS because it's being protected
01:33:38.840 by the fermentation pathways of glucose and glutamine.
01:33:41.860 How much of that lactate is leaving the cell and going back to the liver to undergo the Cori cycle?
01:33:46.580 Yes, a lot of it. A lot of it does.
01:33:48.280 Has anyone ever looked at patients who have a very, very high tumor burden and seen if they
01:33:53.120 appreciably have higher serum lactate levels?
01:33:55.280 Yes. Blood cancers have been. In fact, there have been some patients who have had various
01:34:00.460 leukemias where they died of lactic acidosis from so much lactic acid being produced from
01:34:05.240 the tumor cells. There's a couple of papers reported on that. Lactic acidosis from massive
01:34:10.300 leukemias. Okay. So the leukemia, the same thing. It's a blood cell. They're mitochondria
01:34:15.360 defective. So they're thrown out a lot of lactic acid.
01:34:17.000 Although that's a confusing one because I could come up with another explanation, which is
01:34:20.820 in very, very severe leukemias, you could also create multiple end organ ischemia just due to
01:34:28.060 the defective nature of the white blood cells could actually cause capillary damage. And that
01:34:34.100 lactic acidosis could actually be from other organs.
01:34:36.420 That's true. And the paper that I read seemed to focus on the lactic acidosis from the cancer
01:34:41.320 cells themselves. But it doesn't rule out what you just said.
01:34:44.100 Yeah. And I don't know how you'd quantify the distinction.
01:34:46.020 No, it's another one of these things. But the question is, but you're right. You can't
01:34:50.360 like a solid tumor seeing a lot of lactic acid in the bloodstream. The Cori cycle clears it
01:34:58.160 out pretty quick. So you're going to be taking that lactic acid and making glucose again from
01:35:02.760 it, which then goes back to the tumor cells upregulate the machinery. I believe MCT2 is
01:35:08.220 the lactate transporter. Do they upregulate that specifically?
01:35:12.020 Yeah. I mean, it's upregulated and so is lactic acid, LDHA, lactic acid dehydrogenase A, which
01:35:20.120 converts pyruvate to lactic acid rather than B. See, most cancer cells do not have elevated
01:35:26.040 levels. This is why some people say, oh, cancer cells can burn lactic acid. Oh, where are they
01:35:30.900 burning it? Oh, well, because they're taking it back in. The cancer cells are burned. No,
01:35:34.540 that's bullshit. If it can't put pyruvate into the mitochondrids pumping lactic acid, how is it
01:35:39.560 possible? We're going to take lactic acid and make it back to pyruvate and put it in there.
01:35:42.540 If it does that, and it's going to go up to, you're going to store it as glycogen. It's not
01:35:47.160 going to be respired. But do you know if anybody's looked at that and seen if MCT2, I think it's MCT2
01:35:51.780 is the transporter. It should be upregulated a lot. Yeah, they're upregulated. There's no question
01:35:56.720 they're upregulated. Because otherwise the hydrogen ion would poison the cell. Yeah. So you have the
01:36:00.920 whole thing is upregulated, monocarboxylic acid transporters. They dump out, and they also take in
01:36:06.180 ketones. Don't forget, that same transporter brings in ketones. So when you go into ketogenic diets,
01:36:11.540 the MCTs are upregulated as well. So you're bringing in more ketone bodies now to replace
01:36:17.040 those. There's an irony for you, right? The thing that you use to bring in ketones is giving you
01:36:22.100 the exit for lactate, which protects the cell from the harm of the acidosis that comes with the
01:36:27.960 hydrogen ion. In the microenvironment of the tumor, it's a real mess. So some of the lactic acid is
01:36:34.160 persisting. The hydrogen ions are persisting until they can ooze out into the local bloodstream and
01:36:39.440 get back to the liver that way. But otherwise it's going to be a real acidic mess, which then
01:36:44.300 contributes further to the fermentation behavior of the cells, which then they're resistant. So
01:36:50.080 they're fermenting, right? So they don't need blood vessels. So this is the whole why the
01:36:56.660 anti-angiogenic field has failed. Because they said, well, we'll target the blood vessels and therefore
01:37:02.340 the cells will die because they can't get the oxygen and whatever. But the cancer cell doesn't
01:37:06.360 need that. I mean, it doesn't need the blood vessels. It can ferment.
01:37:09.500 Did you know Judah Falkman, by the way? You guys were basically neighbors here.
01:37:12.700 Yeah, yeah. I know he came down here, gave a talk. He targeted some unusual kinds of cancers with his
01:37:18.980 anti-angiogenic. But Napoleon Farrar, I believe, was the guy who started taking that all off. And he
01:37:24.160 even came to a meeting and said, none of this stuff is working. Well, because the... And this is why
01:37:28.380 Avastin, as I wrote, avoid it like the plague. It's a stupid drug. It was taken off the market
01:37:33.880 for breast cancer because it was harming more people than it was helping. But they still use
01:37:38.020 it for brain cancer. And I think it makes people...
01:37:40.260 They still use it? Do they still use it for colon cancer as well?
01:37:42.420 I don't know of colon cancer, but certainly for brain cancer. So what are you doing? You're
01:37:46.960 targeting the blood vessels and then forcing these cells to spread throughout your whole brain.
01:37:50.660 So just for the listener, right, Avastin is an anti-angiogenic drug. This was a genentech
01:37:54.920 blockbuster, right?
01:37:55.760 But Bevacizumab is the name of the drug. Yeah. And they still use it. I think it's despicable
01:38:00.180 to consider anybody using it. I mean, don't they know the biology of the problem? They would never
01:38:03.980 do that. And it's already been a bust in all the brain cancer studies that I've seen. In fact,
01:38:08.600 my friends have told me that work on this. But it makes the aim...
01:38:12.160 Well, it's generally been priced out of use. Certainly outside of the US, I don't think
01:38:16.320 any third-party payers would cover it. And it's a very expensive drug. It's about $100,000 a year drug.
01:38:21.460 Yeah. And all it does is contribute to the invasive behavior of your tumor cells.
01:38:24.520 And all of these other things, you're basically driving this idea, which I haven't wrapped my head
01:38:28.080 around yet, is you're actually enhancing the promotion of the hypoxic factors that are giving
01:38:35.080 cancer some of its selective benefit.
01:38:37.220 Yeah. And it's forced... And don't forget the cells that are invading, which are coming from
01:38:41.260 disrupted microglia in the brain, macrophages. They'll invade. They already have the capacity to
01:38:46.460 do this. They live without blood vessels. So you're facilitating the invasive behavior. And this
01:38:52.400 has been seen on histological preparations, like brains that have been looked at after
01:38:56.700 Avastin. They find tumor cells spread through everywhere in the brain. Rather than clustered
01:39:00.380 in one area, it's like they've just gone everywhere. But when you look at the image,
01:39:06.620 the radiographic images, it looks good because you don't see the necrotic area that you would
01:39:11.720 normally say, oh, it looks like it's like... The image looks a little bit better. You tell the patient,
01:39:15.540 it looks like it's working. But the overall survival is no different. Sometimes it's even
01:39:20.340 less. So it's a false image of what's going on. You can't see the big central area. It looks like
01:39:26.060 it's very vague and diffuse. And you look at the panel, yeah, it looks like this thing is working.
01:39:30.860 Gives the guy false hope. Because the end result is look at the overall survival statistics and
01:39:36.480 they're abysmal.
01:39:37.600 So I want to go back to something you said a moment ago. You said macrophage, which reminded me of a point
01:39:41.640 you brought up earlier, which I guess I'm just not really familiar with, which was the idea that
01:39:45.560 the macrophage themselves may be responsible for actual metastatic behavior.
01:39:52.780 Yes.
01:39:53.100 Can you say a bit more about that?
01:39:54.280 Well, this is a concept that goes all the way back to Akil from 1906 in Germany, where he was
01:39:59.920 able to show that in colon, I believe it was colon or melanoma, I can't remember the tissue. He was
01:40:05.940 actually observing fusion behavior between the neoplastic cells and the cells of our immune
01:40:11.820 system. And then claimed that he thinks after this fusion event, that these cells become much
01:40:17.820 more aggressive and much more dispersive than before these fusion events. This was then solidified by the
01:40:24.160 work of John Pawlik at Yale University, where he did some beautiful experiments showing that malignant
01:40:29.040 melanoma is actually a macrophage disease. They're resulting of fusion hybridization.
01:40:33.500 This was then further established by Melissa Wong and her group at the Portland Medical Center there,
01:40:39.480 the Health Science Center in Portland, Oregon. Beautiful work showing how in the colon,
01:40:45.500 how macrophages were fusing with neoplastic stem cells forming these hybrid cells.
01:40:51.820 So the question, and we know that all these metastatic cancers are highly fermentative,
01:40:56.380 all right? We know that's a fact. They're all highly fermentative. And they're all very,
01:41:00.880 very invasive and they spread. They migrate through the blood brain. They migrate everywhere. They just
01:41:06.320 invade. And these are all behaviors of macrophages. When you say fusion, so you have a neoplastic cell
01:41:13.700 that is above the basement membrane and you have a macrophage. And tell me what the fusion actually
01:41:21.460 is. Are they fusing genetic material or are they just fusing cytoplasmic material? What's actually
01:41:26.740 happening? Well, it's a combination of both actually. So macrophages, the cells of our immune system are
01:41:31.840 extremely fusogenic. Okay. They do this to wound healing. Like you'll see multinucleated giant cells
01:41:38.080 in a lot of parts of our bodies during wound healing and this kind of thing. And cancer cells,
01:41:42.620 you also find a lot of these multinucleated kinds of cells. So our body recognizes wounding
01:41:48.360 as an acute problem and the immune system will come into that local area to facilitate wound healing.
01:41:54.300 And when the wound persists, sometimes these cells will fuse with each other and fuse with other
01:41:59.440 cells in the microenvironment to facilitate wound healing. The problem is, is if you have an epithelial
01:42:04.880 cell like a breast cell or a colon cell that is coming and becoming neoplastic, becoming dysmorphic in
01:42:11.540 its growth regulatory and it's fermenting, but it doesn't have the capacity to grow anywhere outside of
01:42:17.520 that local area. It doesn't have, have the capacity. So our immune cells come into this
01:42:23.340 lesion, if you will, that's persisting. The immune cell throws out growth factors and cytokines to
01:42:29.080 facilitate the wound, to facilitate wound healing. The problem is those factors are also facilitating
01:42:34.680 the growth of the neoplastic cell. So the neoplastic cell is dysregulated, but the very cell that's coming
01:42:40.340 in to try to correct the wound is now provoking the cell to grow even more.
01:42:44.380 But what is the wound that the macrophage is coming in to see? Because the neoplastic cell has not yet
01:42:49.780 violated the membrane beneath it.
01:42:51.900 No, but it creates a, it throws out lactic acid and creates a kind of a hypoxic micro area. Okay.
01:42:58.420 A micro area of hypoxic, because the lactic acid is a signal of hypoxia. It's a signal of some sort of
01:43:04.440 damage. And you're not supposed to have pockets of build up lactic acid in parts of your body.
01:43:09.600 So it sends out, and normally if this does happen, if we have a contusion or a cut,
01:43:15.200 cells of our, the monocytes mass migrate out of the bloodstream, go into the wound,
01:43:20.160 clear up the debris, kill the bacteria, and then move out of that, out of that section,
01:43:25.160 go back to local lymph nodes and sit there in the event that they need it again. Or if they're
01:43:29.100 pus, they form pus. They're all massive numbers of white dead blood cells. So these cells are part
01:43:33.820 and parcel of the correction of the wound. The problem is in the, if you have a colon lesion
01:43:38.780 or a breast lesion from an occluded milk duct or whatever, or a lesion in the colon, you have
01:43:43.460 population of cells that will start to proliferate, creating a damage to the local micro environment,
01:43:48.440 signaling a system that's immune. There's something going on here.
01:43:52.180 Right. So when the monocyte gets out and differentiates, become the macrophage, goes to this
01:43:56.780 now poorly differentiated cell. Why doesn't it just kill that cell non-specifically? Because
01:44:04.080 this is just a macrophage. And how does that-
01:44:06.420 Well, macrophages aren't designed to kill cells. They're designed to kill bacteria that may be in
01:44:10.280 the micro environment. Don't forget they're a wound healing cell.
01:44:12.620 But going back to the bruise example, right? So you get a contusion in your thigh.
01:44:17.080 The macrophage does play a role in clearing that cellular debris.
01:44:21.120 Yes. Yes.
01:44:21.760 So why doesn't it just effectively do the same thing with the cancer cell or with the soon to be
01:44:25.580 cancer cell?
01:44:26.080 Yeah. Because the cell is not recognized as being, it looks like it's a part of the local
01:44:30.140 normal epithelial cells. Okay. It's not looking at it as if this is a foreign invader. This cell
01:44:36.940 has all of the, it looks like a regular epithelial cell that's proliferating. Because don't forget,
01:44:41.640 we replace our cells by proliferation.
01:44:44.280 But the lactate secretion, which is what got it there in the first place, wouldn't that tell the
01:44:48.860 macrophage, hey, something's still wrong here?
01:44:51.260 Yes. This cell is hardwired to do what it's supposed to do. It's not like thinking,
01:44:55.580 oh, let me problem solve. It's not a problem solving cell. It's hardwired to respond to a
01:45:01.620 particular environmental issue.
01:45:03.820 I see. So you're saying the lactate is the fire alarm that got it there, but then when it gets
01:45:08.440 there, it doesn't see the fire.
01:45:09.620 No. Well, it tries to put out the fire, but the problem is the molecules that are used to put out
01:45:14.880 the fire are actually stimulating the growth of the cell that shouldn't be grown. So it's out of
01:45:18.800 context.
01:45:19.240 Okay. So how does this facilitate metastases rather than just local advancement?
01:45:23.400 Right. So at what point in this protracted process does this now spring to become a
01:45:31.340 metastatic lesion over a controlled proliferative abnormality that's not yet breaking through the
01:45:39.420 basement membrane or doing this, right? So we don't know. Sometimes this can happen very fast.
01:45:46.000 Sometimes it takes a long period of time because we have these certain cancer cells called cancer
01:45:51.420 of unknown primary. They're highly metastatic, which is where the hell they came from, right?
01:45:54.720 We don't know what's, but they're very highly invasive. Then we have other cells that will,
01:45:59.940 well, he had a lesion there a long time for several years. This thing never healed. It was always oozing.
01:46:04.740 It was, and eventually explodes into a metastatic lesion. We don't know at what point,
01:46:09.700 and it varies from one person to the next. Now what happens is when the macrophages,
01:46:15.320 we know biology, they're fusogenic cells. There's massive amounts of biology to show that
01:46:19.900 macrophages are very fusogenic cells. They can fuse with themselves or with other fibroblasts. They can
01:46:24.820 fuse with a variety of different cells. Usually that's part of the wound healing process to facilitate
01:46:29.340 wound healing. But if you fuse with a stem cell that has already defective respiratory systems,
01:46:36.400 you would then dilute the cytoplasm of the cell that you fused it with. And it fuses again and
01:46:42.520 again. It's a process that takes place. You eventually dilute the normal mitochondria in
01:46:47.280 the macrophage, and you replace it with the abnormal mitochondria from the cells that you're
01:46:51.460 fusing with, then leading to a cell with dysregulated growth properties. How many mutations would it take
01:47:00.700 to do that? We don't know because there are some metastatic cells that don't have any mutations,
01:47:04.140 if you can believe it. Deep sequencing. They haven't found any mutations in some of these cells.
01:47:09.160 So, but they're fermenting and they're spreading. They have their growth dysregulated. So-
01:47:14.300 But wait, how are they growth dysregulated without a mutation?
01:47:17.300 You have cells that are carcinogenic, that are tumorogenic, that have no mutations. Baker pointed
01:47:24.880 this out. It's like people can't believe this. On the other hand, we have skin cells loaded with
01:47:29.420 so-called driver mutations that never form a tumor. So, this linkage between the number of mutations
01:47:36.380 and the type of cancer is just, there's so many flaws in this. So, there are cancer cells that have
01:47:43.460 been looked at that have highly invasive metastatic, and they can't find the mutations in there. That's
01:47:50.600 not common, but it happens. So, it throws it. It's a violation to the whole concept.
01:47:55.560 In glioblastoma, there are some tumors that have been found that have none of the driver mutations,
01:48:01.380 none of the abnormalities that you would have expected that are found in others. So,
01:48:05.920 there's a break linkage between mutations. You don't need new mutations to cause a metastatic
01:48:11.220 lesion. That doesn't mean that a metastatic lesion has no mutations.
01:48:14.940 But maybe I'm asking a different question. Okay. So, two women have breast cancer.
01:48:20.640 Right. And for all intents and purposes, they have very similar patterns of mutations in their
01:48:28.320 breast cancer. And let's just say, make it easy and say that they're hormonally similar. They're
01:48:32.800 ER, PR positive, HER2 new negative breast cancers. Both women present as stage T2N1, right? So,
01:48:42.980 they've got whatever, a five centimeter tumor, if that's still a T2, I don't even remember. And
01:48:47.060 they've got, you know, two lymph nodes or one lymph node. They both have a resection.
01:48:51.140 10 years later, one of them is still disease-free. The other one has died from brain metastases,
01:48:57.880 which were presumably seeded before the primary tumor was resected 10 years earlier. It's not a
01:49:04.620 sloppy surgery where they didn't get part of the cancer. What I'm hearing you say is,
01:49:09.560 yeah, one of them could undergo metastases while the other one did not, even though their primary
01:49:14.940 tumors looked very similar. Is that a correct inference?
01:49:17.580 Yeah. I think that's correct. And what we find now with a number of papers is the needle biopsies
01:49:23.240 that are used to diagnose the tumors can create a wounded, even a more aggressive wounded situation
01:49:30.520 in the microenvironment of the tumor, leading to the phenomenon of inflammatory oncotaxis,
01:49:35.920 which facilitates the fusion. And in other words, by looking at the tumor with a needle biopsy to make
01:49:42.200 the diagnosis, you put that patient potentially at risk for causing a metastatic lesion. And then
01:49:47.140 when you look at the profile, you say, well, this doesn't look too bad. No, not here.
01:49:51.780 But wait, let's say we do that. We're going to immediately resect that tumor anyway. So how is
01:49:56.840 that, how quickly does this process take place? Because the wound is between the outside world and the
01:50:02.560 tumor, not between the tumor and the inside world necessarily, especially if that tumor is going to
01:50:07.660 come out within a few weeks, right? Yeah. We know from a number of studies that needle biopsies
01:50:16.460 can facilitate in some patients the invasion of cells into the local and spread. All right. We know
01:50:24.460 this. This has been reported in the literature for breast, for colon, for liver, for brain. The very
01:50:29.840 act of stabbing this growth can. Well, but, but yeah, no, I think what's. So then you can get the
01:50:37.020 cells out. Yeah, but I think what's known is that you can seed tumors along the tract of where you do
01:50:42.160 that. Yes, that I understand. But maybe I misunderstood. You're saying that a woman who
01:50:46.060 has a needle biopsy of her breast, who then goes on to get a lumpectomy, has that increased her risk of
01:50:51.940 brain metastases? Well, it wouldn't be brain metastases right away. It would have to, that brain
01:50:56.560 metastases, the secondary metastatic behavior has taken a while. There's other, it's not just the
01:51:01.960 brain. But how does a needle biopsy increase the risk of that? The needle biopsy creates a more
01:51:07.120 inflamed condition. That's why you call it an inflammatory oncotaxis. And now this was one of
01:51:11.700 the reasons why they get rid of the morcellation procedure, because this is what was happening.
01:51:16.060 So these women were dying from metastatic cancer from morcellation. It's kind of a machine that used to be
01:51:21.540 made by Johnson & Johnson for removing uterine polyps. Well, you're taking a polyp and you're
01:51:27.880 grinding it up and creating inflammatory oncotaxis. Now, there might've been one polyp out of a
01:51:33.980 thousand that would have this. Right, but that's very different from the, I'm asking a very specific
01:51:38.100 question because here's my fear. What I don't want is anybody listening to this who's got a breast
01:51:43.760 lesion who thinks now they can't have it biopsied. I'm still, I think that's a very different case than
01:51:48.180 the example. Well, the evidence is clear in some cases, not all cases, not everybody who goes under
01:51:53.560 a needle biopsy is going to have metastatic cancer. No, but that's not the question. I mean,
01:51:56.940 what I'm asking is, is a woman, if you take a thousand women, you take, it's a thought experiment.
01:52:03.820 You take a million women with an identical breast cancer and you take half a million of them and you
01:52:11.480 just do the resection and the other half a million, you do a needle biopsy to confirm the diagnosis.
01:52:17.240 Then you do a resection. Are you saying in the half a million women that had a resection following
01:52:23.940 a biopsy, their probability of metastatic cancer later on is greater? I think so, but I can't be
01:52:30.540 sure because that experiment hasn't been done. Okay. I'm basing it on what has already been known
01:52:34.800 about needle biopsies facilitating the spread of the tumor. But I, again, I'm just being critical of
01:52:40.160 this because I feel very strongly about not causing panic in people, but I think those data are about
01:52:46.560 needle track seeding. Yeah. Well, needle track seeding. For example, like, as you said, you have
01:52:50.160 a liver biopsy, you can, you can get cancerous cells through the tract even after the, but that's
01:52:55.460 very different from saying, you know, cause that, that can be dealt with, but this is a very different.
01:53:00.540 Yeah. Well, I think this is from what I'm looking at. Now I look at the brain predominantly,
01:53:04.380 right? You know how many we have, what we call secondary glioblastoma. And that is a very,
01:53:10.300 it's not uncommon that when you go in and remove a low grade tumor that within a shorter period of time,
01:53:15.700 it turns into a glioblastoma. This is the same phenomenon. You're just doing it on a little bit
01:53:20.760 larger scale rather than just through a needle biopsy. So you go in and you take out a low grade
01:53:25.220 tumor and all of a sudden within a year or something, you've got glioblastoma, sometimes even
01:53:29.520 less. And you're saying, what the hell happened here? So this is just a larger, what's the control
01:53:34.180 for that observation? Well, there meaning like another explanation would be the person who has the
01:53:39.560 stage one astrocytoma is more at risk for the stage two, three, or four astrocytoma.
01:53:45.260 From the operation itself, from the provocation of the micro environment.
01:53:49.180 But without it, we'd have to have a group of those patients who don't undergo surgery.
01:53:52.160 That's right. And you would have to, but who's doing, nobody's doing these experiments,
01:53:56.040 but we, but here, here's the situation. What our philosophy is that is if we shrink the tumor,
01:54:02.360 whether it's a breast tumor, colon tumor, or whatever, if we take away the fermentable fuels
01:54:07.280 and shrink that tumor down, then it becomes a candidate for complete debulking, not, not
01:54:13.260 diagnosing. Okay. When you take a needle biopsy of a breast and you look at what are they,
01:54:20.660 why are they doing that? They're doing it for majorly two reasons to try to diagnose what level
01:54:24.360 of cancer you have. And then to give you a gene readout, like these genes are going to play some
01:54:28.960 role in whether or not you're going to get a treatment, right?
01:54:31.280 Well, yeah. But it's, for example, in the case of doing a biopsy before a breast resection,
01:54:37.780 you, there's value in knowing if a woman might benefit from neoadjuvant therapy, for example,
01:54:42.360 based on their receptor profile. Yeah, but in other words, it might not just be the gene,
01:54:46.480 right? Like knowing that she's ER, knowing that she's triple positive versus triple negative might
01:54:51.260 change what you do. Yeah, I guess it could. But, but the bottom line is, is that why don't you
01:54:55.800 assume that you have a problem? Why don't you just put that patient on metabolic therapy?
01:55:01.280 And shrink that tumor down and then do a non-invasive check. Did it, did the borders
01:55:07.760 change at all from the, from the metabolic and then just the bulk it completely? The probability
01:55:13.260 of cure is going to be better in my mind than if you do a needle biopsy without doing the debulking.
01:55:21.260 And just to say, let's look at this. How long after the needle biopsy do you put that patient at risk
01:55:26.860 for possibly seeding a cell that gets into a lymph node that then can spread out and later that you
01:55:33.340 get brain metastasis, liver metastasis or whatever else can happen from these cancers? So the question
01:55:39.020 is why put anybody at risk? If we know we have evidence from the literature to say that is a
01:55:44.880 possibility, why would we want to put anyone at risk for that? Unless the information you get from
01:55:51.860 the needle biopsy is going to be a curative procedure. And a lot of times it's not. Okay.
01:55:56.960 It's just for diagnosis procedures. And now today we're using all these gene screens, $7,200 to tell
01:56:02.900 somebody what kind of gene profile. And that may no longer be relevant after you've taken a needle
01:56:07.780 biopsy from the very tissue that you're doing. Yeah. No, I think that makes sense. I guess I'm
01:56:11.540 a bit confused by the idea. I guess I just don't see.
01:56:15.140 Those are controversial issues. And I'm looking at it from the point of the biological processes
01:56:20.400 that are taking place from these procedures. And knowing that I've seen literature on lung,
01:56:27.000 I've seen on liver cancer, certainly for brain.
01:56:29.340 I mean, but here's, so, I mean, there are so many potential arguments, right? So you look at one of
01:56:35.400 the most metastatic cancers of all time is pancreatic cancer, right? It's almost uniformly fatal. And yet up
01:56:43.580 until recently, very infrequently biopsied. It's a very difficult biopsy. You have to do it with an
01:56:49.360 ERCP. No, that's true. So yet, in other words, you can still have incredibly aggressive metabolic
01:56:54.720 cancers, which have never, which are, you know, are not biopsied often. And then conversely,
01:57:00.000 you look at a GBM, you look at a, you know, the cancer we're sitting here talking about the brain,
01:57:04.680 you know, a very aggressive, the one that John McCain just passed away from. Well, that's,
01:57:09.020 I mean, that's only locally metastatic. It never leaves the CNS, does it?
01:57:13.060 Oh, yeah, it does.
01:57:14.400 Where does it go?
01:57:15.120 It goes to bone. It goes to liver. It goes to, nobody looks at the-
01:57:18.700 What percentage of patients die from, or-
01:57:21.660 Not many, but when they look, they find. This was one of the big things. This is how we
01:57:26.420 discovered the macrophage origin of the cancer. We started looking and say, how many people do
01:57:31.960 autopsies of organs on people who've died from glioblastoma?
01:57:35.780 And what did you find?
01:57:36.800 There's a hundred articles in the literature with metastatic GBM to various organs for people dying.
01:57:42.100 People say, well, it doesn't happen that often. You know why? They die the GBM before they start
01:57:46.100 recognizing they have metastatic liver cancer. But when you look at livers and kidneys and these
01:57:50.600 other organs from patients who have died from GBM, those studies that have looked have found cancer.
01:57:56.040 So clearly, these cells are coming out of the brain, and they're getting into the other organs.
01:57:59.840 The problem is the patients aren't living long enough to have a problem. Well, who's worrying
01:58:03.280 about the guy's liver when his brain is starting to swell up from all the treatments they're giving him?
01:58:07.980 I mean, 12 months, most people are dead. But there's over 100 articles in the scientific
01:58:15.280 literature showing outside, I call it extracranial metastasis of glioblastoma.
01:58:21.360 So it's not that it's, and people ignore it. It's like knowing that the mitochondria damaged
01:58:26.220 in cancer cells, people ignore it.
01:58:28.380 Well, I guess that'd be a more forgivable thing to ignore because I'm not convinced it
01:58:32.980 necessarily changes the story. The mitochondrial one is a much more interesting question, right?
01:58:37.660 I mean, that to me, of all the things we've talked about today, Tom, that's the one that
01:58:41.180 kind of has me scratching my head the most and wondering, in 2018, how are we even having
01:58:47.880 that? This should be something that's not debated. This should be sort of like, this would be like
01:58:52.700 debating whether DNA is necessary to make RNA. That discussion was settled in the 50s, and anyone
01:59:01.120 who disputes that now is sort of disputing the shape of the earth.
01:59:04.680 So I guess, to me, given the stakes here, I would love to figure out why people aren't
01:59:10.340 answering this question.
01:59:11.240 Well, let's look at the situation from even a greater distance. In the United States, we have
01:59:17.160 over 1,600 people a day dying from cancer. I mean, this is horrific, right? There's over a half a
01:59:22.940 million people a year, 1,600 people a day dying from cancer. Obviously, there's something seriously
01:59:28.020 wrong. There's something massively wrong with what we're doing with this disease. You know,
01:59:32.800 we talk about needle biopsies. We're talking about this. We're talking about that. The issue is we
01:59:37.320 had 1,600 people a day dying. Why are all these people dying from cancer? So it's either we have
01:59:42.140 a fundamental misunderstanding of what the nature of the disease is. We're mistreating it. We're
01:59:46.920 treating it as something that other than what it actually is. So the debate that you mentioned now
01:59:52.240 is that the results of the dead people are the consequences of the fundamental misunderstanding
01:59:58.120 of the process of the biology of the disease. What I'm arguing is that now understanding the
02:00:04.420 biology of the disease, we have the potential to drop the death rate by more than 50% in 10 years.
02:00:10.240 There's no question about it. If you stop doing half of the stuff that we're doing to these cancer
02:00:14.360 patients, looking at the biology and the nature of the disease, how to best go about this strategically,
02:00:19.440 I think we can drop the death rate by 50%. We're doing stupid things, right? Needle biopsy tumor cells
02:00:25.640 for genetic profiling that has no relevance to the nature of the disease. That's just one.
02:00:30.780 But just to go back to that, because I'm sorry. I really want to make sure people aren't going to
02:00:35.160 stop refusing their biopsies. But have we seen an increase in the rate of metastases in the era of
02:00:41.560 needle biopsying for genetic sequencing? I mean, we could go back and look at the death rate from
02:00:45.740 cancer 50 years ago before anybody was doing this, and it was the same.
02:00:49.360 Yeah. Well, I think that we've probably... I don't want to say... I just want to say that every
02:00:54.220 year, we have more and more dead people. And the increase is faster than the general population,
02:00:59.480 okay? So we had 3.8% increase in death.
02:01:03.340 I don't know. Is that actually true? Is the age-adjusted, population-adjusted mortality
02:01:09.000 of cancer today higher than it was 50 years ago? I think it's about 3% or 4% lower, isn't it?
02:01:14.360 Well, I just did the last five years, okay, from 2013 to 2017.
02:01:18.680 But to test this hypothesis, we'd want to take an even longer time period and go more extreme as
02:01:23.920 far as like... Yeah. Well, I mean, every year, there's no year that we have fewer. They're
02:01:29.420 always coming. The dead people are piling up. So when I look at the numbers and I say, okay,
02:01:35.000 what was the percent of population increase in the United States over the last five years? And
02:01:40.260 according to the demographics, it's 2.9%. Okay. Over the same period, how many cancer deaths...
02:01:47.000 Right. But again, I don't know my epidemiology well enough to make this case, but I'm going to
02:01:51.160 try anyway. Isn't the growth in population more a function of the input of people, meaning birth rate,
02:01:57.720 rather than the people who are getting cancer, which are the older folks?
02:02:01.920 Well, we have younger people too, right?
02:02:03.720 Right. But the majority of cancers are older folks.
02:02:05.600 Yeah, majority of cancers are older folks, for sure.
02:02:06.700 So I'm not sure that that population argument would answer that question, right?
02:02:11.040 Well, maybe. There's always a guy you can find. I think all you have to look at is the numbers of
02:02:16.800 people that are dying from the disease. I mean, that's a fact. No, it's a fact, and it's a tragic
02:02:21.860 fact. I guess a 50% reduction in the mortality of this disease in 10 years is a very bold statement,
02:02:30.480 given that we've seen about a 3% reduction in cancer mortality in 50 years.
02:02:36.540 Yeah.
02:02:38.240 Which I think you're arguing is unacceptable and understandable.
02:02:41.320 Well, you know, yeah, I'm looking at it from the tragedy. In China, there's 8,100 people a day
02:02:47.240 dying from cancer. I mean, that's the number over there. Maybe that's the bigger population. But
02:02:51.140 the problem, it's now surpassed heart disease in their country. Clearly, it's not whatever we're
02:02:55.880 doing. And yes, 50%, if you did what we think you need to do and to manage this disease,
02:03:03.600 looking at it from the biology of the disease, you will, I think, I would not be shocked if we had
02:03:11.280 a 50% reduction in 10 years. So normally, I ask people what their dream experiment would be. But
02:03:17.760 I want to ask you two. I want to ask you this question twice. The first time I'll ask you this
02:03:23.920 question will be the easier one because it'll be the clinical trial. So what would be the dream
02:03:29.660 clinical trial to test the hypothesis that says we can reduce the mortality of cancer by 50%?
02:03:36.900 What would you want to put head to head to definitively ask that question?
02:03:41.020 Okay. So what we do right now is if we do metabolic therapy at all, okay, we do it at all. It's either
02:03:47.400 standard of care versus standard of care plus metabolic therapy. We're missing the critical control
02:03:53.800 group. Metabolic therapy without standard of care. What are we doing to these people?
02:03:58.860 So tell me what the experiment would be. Let's use breast cancer as an example.
02:04:02.380 Okay. Breast cancer. So you have your standard, whatever you're doing today. You got a lot of
02:04:05.500 people dying of breast cancer, metastatic breast cancer. So we're going to now take metabolic therapy
02:04:10.240 and we're going to combine it with standard of care, which is what the group in Turkey is.
02:04:15.840 And how is that? How would you integrate that? Let's talk about how you would do it,
02:04:19.080 not necessarily how it's being done. How would you, for the purpose of the experiment,
02:04:22.440 integrate standard of care with metabolic therapy?
02:04:23.440 Okay. So we would use the chemo and we would have people on, on metabolic therapy,
02:04:28.740 which would be lower. And you would do those in parallel?
02:04:31.200 You would have some patients that would be treated only with the standard of care,
02:04:35.360 which would, which would be our control. And then we would have people treated with the standard of
02:04:40.000 care plus reducing blood sugar, elevating ketones and targeting the energy metabolism, which we can do.
02:04:47.680 And would that include things like metformin or DCA or other things like that?
02:04:51.980 It could, it could include hyperbaric oxygen.
02:04:54.080 Yes. Yes. And that's what we're doing in Turkey. So it's basically standard. However,
02:04:58.140 in Turkey, we're doing the lowest dose of chemo that we can use to still be in compliance with the,
02:05:03.280 with the law. And if you get rid of now, the control, the...
02:05:07.200 And now your metabolic therapy alone group would be...
02:05:09.280 Metabolic therapy alone group.
02:05:10.040 What would that group?
02:05:10.860 That group would be the press pulse concept. So we down-regulate the glucose first,
02:05:15.680 shrink the tumor up, make the microenvironment less inflamed, less angry.
02:05:20.560 Then we...
02:05:21.240 Specifically tell me what would be in that. So you would put, these patients would be on
02:05:24.760 ketogenic diets?
02:05:25.600 First, we would lower their blood sugar gradually, depending on the status of the individual.
02:05:30.480 So you'd go into lowering their blood sugar, elevating their... Putting them to therapeutic
02:05:34.580 ketosis, essentially. So a lot of these people also have a multiple other series of metabolic
02:05:39.300 abnormalities. They have type 2 diabetes. They've got triglyceridemia. They have all kinds of other
02:05:44.260 things besides having cancer. So basically by bringing them into a state of therapeutic ketosis...
02:05:50.400 And how do you define that? Is that defined by the amount of glucose and ketone?
02:05:53.900 It's by the glucose ketone index that we published. We published the paper on this.
02:05:57.260 And what's the ratio that you...
02:05:58.600 It's a ratio about close to 1.0 or below, if we can get it. This is where the millimolar of ketone
02:06:05.040 and the millimolar of glucose are about the same.
02:06:07.080 And that people hit that somewhere between 3 and 4, I'm guessing?
02:06:10.260 Days after?
02:06:10.960 No. 3 to 4 millimolars tends to be the place where they're about the same.
02:06:14.580 It could be. It could be. It depends on the individual. Because some people have higher
02:06:18.980 glucose, higher ketones, and yet they still have the same ratio. So some people have very low glucose
02:06:24.120 and not that high of a ketone, but it gives them the same ratio. So the issue is get your ratio...
02:06:28.560 The only time I've been able to be at 1 to 1 is when I'm not eating anything.
02:06:32.700 Yeah. Well, it's variable from one person to the next. And then the other thing too,
02:06:36.400 we have to be very careful about, is a lot of cancer patients, very hard to get into 1. You're
02:06:40.800 a young, healthy guy. Guys that are young and healthy can get well below 1. Women are better
02:06:44.840 than men. We've done some studies. So basically... But cancer patients are freaked out because they
02:06:50.460 have anxiety. And anxiety elevates corticosteroids. And you have a tougher time bringing your...
02:06:55.900 So we also institute with the press, besides ketone supplementation, as Dom DiAgostino has
02:07:02.560 been telling, and the ketogenic diet. And then we have stress management, which includes music
02:07:08.200 therapy, yoga therapy. There's a variety of ways to reduce emotional stress. And that's a very
02:07:13.120 important part of the management. You have to let the patient know that their disease is not terminal,
02:07:18.760 that their lowering of the stress is going to make the medicine work.
02:07:23.240 So once we get the patient into metabolic ketosis, now we have options. Now we can start using insulin
02:07:29.800 therapy to bring the blood sugars down lower. We can put them into hyperbaric oxygen, which creates
02:07:34.300 oxidative stress predominantly in the tumor cell and not in the normal cells. The normal cells are
02:07:38.880 burning ketones that reduces oxidative stress.
02:07:41.440 When you say insulin therapies, do you mean actual insulin?
02:07:43.980 Yeah. We're testing that now. The Germans used to do that years ago, but we don't think we have to
02:07:48.400 put people into metabolic comas to do this. We think we can do it without it. We're testing it now.
02:07:52.980 So I'm working on it now. As we speak, we have these experiments going next door.
02:07:57.520 So the question is, you don't want to use insulin therapy unless you're in therapeutic ketosis. You
02:08:02.080 don't want to go into a hyperbaric chamber unless you're in therapeutic ketosis. And then we would
02:08:06.240 pulse with drugs that target glutamine. And together, you're removing the antioxidant capacity of the
02:08:11.700 tumor, making it vulnerable to hyperbaric oxygen.
02:08:14.040 How much can these drugs lower local levels of glutamine?
02:08:17.740 Enough to slaughter the tumor cells.
02:08:19.300 But what is, like, I don't know enough about this. Is that a 50% reduction that's necessary
02:08:22.860 to do that? Because you're getting about a 50% reduction in glucose based on the therapy
02:08:26.860 you've described.
02:08:27.280 We want to lower the glucose even further because you can do that. And with ketones,
02:08:32.440 correction, with targeting glutamine, it's got to be pulsed because you can't chronically reduce
02:08:36.580 glutamine to the availability, to the physiology.
02:08:39.360 But acutely, how much do you lower it?
02:08:40.900 We can lower it quite effectively. We can shut it. And well, don't forget, the cancer cell is
02:08:45.800 absolutely dependent on this fuel. The normal cells, they can burn the ketones also. So they're
02:08:50.420 not going to be energy deprived completely. Whereas the tumor cell will be deprived energy
02:08:55.320 completely.
02:08:55.780 Are there some cancer cells that preferentially utilize ketones?
02:08:59.260 No cancer cell can use ketones. You have to have a good mitochondria. And a cancer cell that
02:09:03.120 would have some oxidative capacity, a small amount of oxidative capacity, could burn some ketones.
02:09:09.660 But most of the most aggressive cancer cells can't burn ketones because they're mitochondria
02:09:14.360 defective, that you need a good mitochondria. That's why it's a selective. It selects for
02:09:19.520 enhancing the vitality of the normal cell while putting the cancer cell at a competitive
02:09:24.300 disadvantage. So the ketones are not to kill cancer cells. They're to provide the normal cells
02:09:29.460 with a fuel as an alternative to glucose, that the tumor cells can't use the ketones.
02:09:34.440 And there are many experiments like this. If you take cancer cells and grow them in a dish
02:09:38.860 without glucose and glutamine, just ketones, they die. But normal cells don't. The normal cells can
02:09:43.880 survive on the ketones without the glucose and glutamine. So it's very clear that the tumor
02:09:47.640 cells can't use it. And as I said, you have to have a good mitochondria to do this. So we're
02:09:52.040 selectively marginalizing these tumor cells because of their metabolic incapabilities.
02:09:56.420 But it has to be done strategically over time.
02:09:59.720 And where does the hyperbaric oxygen fit in? Is that part of the pulse, obviously?
02:10:02.880 Yeah, that's a pulse therapy.
02:10:04.040 And how much hyperbaric?
02:10:07.100 We want to try to replace radiation therapy with hyperbaric oxygen because the mechanisms of cell
02:10:11.860 death will be very similar.
02:10:12.600 So how many atmospheres?
02:10:13.780 We do it at two and a half atmospheres.
02:10:15.740 For how long?
02:10:16.480 Well, we were doing it for 90 minutes every day, something like this. So it's designed to put
02:10:23.600 oxidative stress, killing the tumor cells by oxidative stress, the same way a radiation
02:10:28.500 therapy would work. Radiation a lot of times doesn't work because the cells are in a hypoxic environment.
02:10:33.760 All right? So why are they in such a hypoxic environment? Because they're fermenting.
02:10:37.740 All right? They're blowing out all this fermentable fuels into the waste products.
02:10:41.920 Got to clean that all up. That microenvironment has to be brought back to a normal state.
02:10:47.080 And therapeutic ketosis, we published several papers showing that it's a powerful anti-inflammatory
02:10:54.620 therapy. It makes the microenvironment less inflamed. It's pro-apoptotic. It's anti-angiogenic.
02:11:00.180 So you're killing all these bad blood vessels and replacing them with normal blood vessels
02:11:03.960 that the normal cells will be able to use. So it's reconfiguring the microenvironment while
02:11:10.000 putting stress and killing tumor cells. Now the tumor becomes more and more vulnerable.
02:11:14.600 And now it becomes more and more damaged by drugs that are going to chip away at the surviving
02:11:19.700 cells. It's not something we're going to go in like a bull in a china shop. It's going to be a
02:11:24.080 gradual degrading of the tumor.
02:11:26.580 And where does the surgery take place here? Is the surgery taking place before all of this
02:11:30.720 happens?
02:11:31.180 No. The surgery would take place at some midpoint. Okay? The midpoint would be where the surgeon
02:11:36.300 now looks at the tumor and says, I can take care of this. It's not going to be a diffuse mass. It's
02:11:41.400 not going to be an angry inflamed thing where you have to cut out half the guy's colon in order to get
02:11:45.960 what you think is the part of the cancer that's it. No, this thing will be now much more shriveled.
02:11:50.900 We've seen it. It's much less angry. It's a micro, it's more demarcated. You can see it on this,
02:11:56.060 and the histological slides. You can see what the hell happened to this tumor. How come it's
02:12:00.840 smaller? How come it's more, the margins are more sharply defined? Because you took away
02:12:05.380 the inflammation that was being driven by the fermentation fuels. So you're shrinking this
02:12:10.760 tumor down. Now the surgeon comes in and can potentially cure these people that would be
02:12:16.520 maybe not curable in the past. So this is why I'm saying we can reduce the death rate by 50%
02:12:22.580 if you view the tumor as a metabolic problem rather than a genetic problem. The gene mutations
02:12:29.080 are all downstream epiphenomen. They're red herrings. Even Vogelstein, who still claims that
02:12:33.940 this is a bird Vogelstein from China, he still claims it's a genetic disease, but we're never
02:12:38.060 going to cure the disease by targeting the genes. There's too many mutations. It's all this kind of
02:12:41.880 stuff. But we can do that with metabolic therapy. We can actually eliminate the cancer based on
02:12:47.300 metabolic therapy. It's a process. Who's trained to do this? No one. I mean, we need physicians to
02:12:53.280 be trained to do this. They've been used to train to give high doses of radiation without killing the
02:12:58.780 patient or poisoning these poor people with drugs that are very toxic and keeping them alive so you
02:13:03.320 don't die from the treatments. This is absurd. Why are you using radiation and chemo in the first
02:13:08.860 place? Well, we have to stop proliferation. Okay, well, if they can't generate energy, they're going
02:13:13.440 to stop proliferating. They're going to die. What is the experiment, the clinical trial that
02:13:17.240 you're involved in in Turkey that you've alluded to? Yeah, so what we do, my colleagues in Turkey
02:13:21.660 do, is they use chemo, but they use the lowest possible dose. Is it for breast cancer? All cancers.
02:13:27.060 In fact, the results are the same. All cancers are the same disease. They're all fermenters. So once
02:13:31.020 you knew that they're all dependent on these two fuels, then all you have to do is target the two
02:13:35.560 fuels to put them at risk for elimination. The question is, how can you target the fuels without harming
02:13:40.960 the rest of the body? And that's the press pulse concept. So we know we can press things constantly
02:13:45.680 without harming the body, but we have to pulse the glutamine issue because we don't want to deprive
02:13:51.020 our normal immune system and gut systems of the very fuel needed to provide normal physiology in
02:13:56.020 those tissues. So this is why we have to pulse the glutamine issue. How many glutamine drugs are there?
02:14:01.520 Well, there's some coming all the time, but the one that works the best for us is Don.
02:14:05.780 Are there any that are in clinical trials in the United States?
02:14:08.140 Yeah. There's a couple. There's a few names of them. They target various aspects of the
02:14:13.420 glutaminolysis pathway. The problem is we have a drug that's called a dirty drug. It hits multiple
02:14:19.680 pathways of glutamine metabolism, and it seems to work better than all the other drugs, at least from
02:14:24.600 our perspective so far. Which drug is that?
02:14:26.760 This is Don, the 6-neuroleucine. It was used in clinical trials years ago, but it was partially
02:14:32.380 effective, but they weren't targeting. They weren't doing the full metabolic approach. If you don't do all
02:14:36.540 the parts of the problem, the horse is going to get out. It's still not going to be effective.
02:14:41.900 And today, no one anywhere on the planet is doing the kind of a therapy that we think need to do to
02:14:46.820 make this all work. Now, there's bits and pieces of it.
02:14:49.300 And then what are the drugs that are in current clinical trials that are targeting glutamine?
02:14:52.900 Well, there's a BEPTS, I believe, an acronym for another very complicated structure.
02:14:57.180 And then they're making Don analogs that are supposedly less toxic. What we find is with
02:15:02.520 the ketogenic diet, Don becomes far less toxic. So you can actually use far lower doses.
02:15:09.300 So I was talking to somebody the other day, is it better to wait for a pharmaceutical company to
02:15:14.160 build a new drug to target cancer, or is it better to develop a way in which a previously very effective
02:15:20.960 drug could be less toxic? And both of them, the end result is the same. You're going to get something
02:15:25.460 that's going to work far better than what was previously available. So how many clinics in
02:15:30.080 the country, in the world, are treating cancer as a metabolic disease using a strategy that will
02:15:36.260 take away the two prime fermentable fuels for the disorder? And the answer is no one. No one's doing
02:15:41.580 this. But this trial in Turkey is doing this? Well, they're not targeting the glutamine. So they're
02:15:47.100 doing these other processes. So it's the glucose, the ketones, the hyperbaric oxygen, but not pulsing with
02:15:54.720 glutamine, not the anti-glutamine. Not doing the glutamine. Nobody's doing the glutamine.
02:15:58.400 We tried doing that in our Egyptian patient that we published recently. We used chloroquine and we
02:16:03.140 used EGCG, which is a green tea extract. But they're not as powerful in the clinic. Now that poor
02:16:10.120 guy, he just passed away. We were devastated by this. We published the paper. He lived 30 months,
02:16:14.840 which is far longer than most people with a glioblastoma. He was doing really well
02:16:18.760 on metabolic therapy. We pushed off the standard of care for three months. So we did surgery after
02:16:25.020 three weeks of therapeutic ketosis, debulked the tumor, most of it, because you never get all GBM.
02:16:31.320 And then we were forced into the radiation therapy after three months, even though the guy was doing
02:16:37.340 remarkably well. So we said, why are we irradiating? Well, we have to, because it's part
02:16:41.600 of the standard. Even in, this was in Alexandria, Egypt. And then a year later, he starts developing,
02:16:47.460 or what, six or eight months later, he starts developing a headache. His head starts to swell.
02:16:53.820 And they did the compression, the bulking, and they found, looked at the tissue. There weren't
02:16:57.760 any tumor cells. It was dying from radiation necrosis that he took from the radiation.
02:17:02.200 So this is why I'm very much against it. I think we're not going to make any major advance in brain
02:17:06.540 cancer until we stop irradiating people with the brain, because you're creating a bigger problem.
02:17:10.540 And this is leading to the demise of all these poor patients. The survival after radiation is
02:17:15.840 almost zero. And that's, in my mind, it's becoming, it's doing in part to the radiation
02:17:22.060 that we're giving to these people. So whether they're dying from the tumor or radiation necrosis,
02:17:26.040 they're going to be dying. They shouldn't be doing that in the first place. So the standards of care
02:17:29.800 have to be dramatically changed in order to improve overall survival. So when I say we can drop death
02:17:37.080 rates by 50% in 10 years, we're not only dropping death rates, we're massively increasing overall
02:17:42.420 survival and quality of life at the same time. So I have a lot of anecdotal information with people
02:17:50.260 who have been treated with metabolic therapy, part of it. They're living far longer. Their quality of
02:17:55.080 life is much better. And when they die, they die in a very peaceful way. And some of my clinician
02:17:59.640 friends have been telling me this, these guys that are in these metabolic therapies. Their quality of
02:18:03.360 life is really good up until about two weeks before they die. Whereas the people do on standard
02:18:07.280 of care, never live as long. And their quality of life is horrific. They're living there. They're
02:18:11.640 incapacitated. So do you think that metabolic therapies offer the potential for cure or just
02:18:17.680 another therapeutic option? Because if you want to reduce the death rate by 50%, there's no lead time
02:18:24.760 bias slash therapeutic extension that's going to do that. That is a paradigm shift in cure, not treatment.
02:18:32.680 I think it's both. I think you're going to be able to extend dramatically overall survival. You're
02:18:37.880 going to improve dramatically quality of life. And how do we know if we're cured? The issue is that
02:18:44.900 if you die from a heart disease at 85 and you had cancer when you were 50, a so-called a terminal
02:18:51.360 disease.
02:18:51.820 No, I mean, I think we could pick something simpler than that, right? If you are 10 years disease-free,
02:18:57.600 to a first order approximation, you're cancer-free, right? If you had colon cancer 10 years ago,
02:19:02.660 and 10 years later, you die of a heart attack, I think it's safe to say you died of heart disease,
02:19:07.760 even if on an autopsy they find dormant cancer cells.
02:19:11.900 Well, here's a situation. If you take standard of care and you live 10 years, or like you said,
02:19:18.500 and you drop dead of a heart attack, was that heart attack the result of the cancer or the
02:19:23.980 treatment? You also have to put into perspective, what effect does the treatments have on your overall
02:19:30.160 long-term survival as well, right? So Dana Farber down here just opened up a branch of medicine
02:19:35.500 called cancer survivor medicine. It appears that many people treated with standards of care are
02:19:39.840 suffering from, horrifically, from all these other kinds of diseases they never had but for the fact
02:19:43.500 that they were treated with all this toxic stuff. So we would eliminate that. Why would you,
02:19:47.540 if you're in therapeutic ketosis and you're, it's unlikely-
02:19:50.400 But I'm still like, what's the proof of concept that the metabolic
02:19:53.480 therapy can lead to a cure? So is your hypothesis that this gentleman in Alexandria,
02:19:59.820 if he hadn't been, if he hadn't undergone radiation for the GBM, your belief is he could
02:20:06.180 have actually had a cure? I don't know because we can't know, like you said, we'd have to wait 10
02:20:11.200 years to know that. So if we were to institute an aggressive metabolic program for managing cancer-
02:20:17.500 But it seems GBM would be the place to do it, right? Because it's, you know, it unfortunately-
02:20:21.820 Unfortunately, it's such a uniformly fatal cancer.
02:20:24.660 And it's fatal because of the treatment that they're giving these, this combination of what
02:20:28.620 they're doing to the patient as well as the tumor.
02:20:32.060 The problem clinically, right, is that the mass effect doesn't give you a lot of flexibility to
02:20:39.440 delay surgery. So between corticosteroids and radiation, when a patient, some of most patients
02:20:45.440 present with GBM, not as incidental findings, they have symptoms from the mass effect. So
02:20:51.240 we have to be sympathetic to the clinicians in the conventional pathway who are saying,
02:20:55.760 look, I got Bob here. He's complaining he's got, you know, hemiparalysis and he's got a GBM.
02:21:03.360 The idea that we're going to wait a month to put him on a ketogenic diet when I need to either cut
02:21:08.160 that thing out now or radiate him or put him on corticosteroids. So in other words, this is going
02:21:13.980 to be a very difficult thing to study.
02:21:15.320 Well, it's a judgment call on the part of the neurosurgeon. Okay. So he looks at the data.
02:21:19.760 Do we have a watchful waiting period? This is, I've spoken to many neurosurgeons,
02:21:23.980 a lot of my friends. I said, what's the stat? What do we do here? He said, occasionally,
02:21:28.380 if you have brain herniation possibility, the patient will be dead in a week. We don't do
02:21:32.000 debulking. That patient has to be debult. All right. But you don't have to give them steroids.
02:21:36.660 You can just do debulking. Steroids will shrink the edema.
02:21:39.880 Yeah. Of the three, what would be the most evil in your mind? Meaning metabolically evil,
02:21:45.500 the radiation, the corticosteroid, or the surgery?
02:21:47.800 Oh, clearly the steroids and the radiation.
02:21:50.640 So then it would seem to me that every GBM patient should go and have the resection
02:21:54.800 and then undergo metabolic therapy, even though they're not technically going to be free of
02:21:59.740 disease. Yeah. I think this is the strategy. How long the watchful waiting period is will give the
02:22:06.060 neurosurgeon an opportunity to do a greater debulking? And there's a hundred articles in
02:22:11.020 the literature showing that the lot you live longer on debulking, the more you can debulk the
02:22:14.900 tumor. So if we can shrink the tumor down, like we did to the, on our Egyptian page, we waited three
02:22:19.780 weeks. We put them under incredible therapeutic fasting, water only, 900 ketogenic diet. They did a
02:22:25.840 very awake, good 900 calories, kilocalories. Yeah. But not water only, you said. Water for the first
02:22:32.380 three days, water only. I see. And then we transitioned him. He did an awake cradionomy.
02:22:37.540 It was done very well. Then we pushed off the radiation therapy for three months. And then they
02:22:42.740 did, and we didn't want to do that because the tumor was looking really good. He had a correction
02:22:47.260 of the midline shift. He was in good shape. So I think he suffered from the radiation. I think he
02:22:53.780 didn't survive because of the radiation treatment. Do you think that GBM would be the best histology to
02:22:58.960 study this in? Oh yeah. Because it's the, as you said, the survival is. You're going to see a signal
02:23:04.400 if one's there. Yeah. So, and then I've spoken to a lot of my friends who think that, okay, we have
02:23:10.120 to debulk immediately. Then we're going to go to metabolic therapy. We can push it off for two weeks
02:23:15.140 and then do metabolic therapy. The thing we have to do is we have to eliminate radiation. I think
02:23:19.640 radiation is part of the big, biggest part of the problem. I think when you do, if you're doing
02:23:23.420 metabolic therapy, you should eliminate radiation right away. I have no doubt about this. This is
02:23:27.720 absolutely, in my mind, a problem. And this is one of the reasons why there's so few people
02:23:33.300 surviving. It's because you are radiating this. If you didn't irradiate, you could survive a lot
02:23:37.860 longer. I think with metabolic therapy, you can double, triple the amount of survival. How do we
02:23:42.620 know this? Because those patients that I know who rejected radiation and chemo, took surgery after two
02:23:48.260 years, a year, are doing well. They're out four years. So clearly- With which histologies?
02:23:53.280 GBM. There are GBM patients alive? Yes. At four years? Yes. Pablo Kelly. In fact,
02:23:59.600 I'm going to be there next week. He's going to be sitting in the audience. Is this published?
02:24:03.020 No, it's not published, but the guy has all the documentation. It's just that it's not yet
02:24:06.860 published. Why? Because I haven't sat down and wrote it up yet. What would be more important than
02:24:12.340 writing that up? Writing another paper up that I thought the guy was going to live just as long,
02:24:16.240 but he was already- No, no, no, no. Look, that guy was one guy alive three years. If you have a cohort of
02:24:21.260 patients that have been alive for four years with GBM, I don't know what would be more important
02:24:25.720 than writing that up. Do I? I don't know of anything more important either, but you don't
02:24:28.800 forget- We should stop this podcast now so you can start writing that up.
02:24:31.660 Well, I'll talk to him. In fact, he's going to be giving a lecture after my lecture.
02:24:36.320 Because that's, I mean, that's really where you want to be able to generate interest on a clinical
02:24:39.720 trial. Okay. So how many people, he's a young guy, 25 years old. He says, I don't want radiation.
02:24:45.040 I don't want chemo. I don't want any of that stuff. I don't want surgery, he says. Oh, you're going to be
02:24:49.360 dead in three to six months. That's what they told him. It's all in the news. It was in the
02:24:52.360 newspapers. I gave him the stuff on the metabolic therapy. I didn't know he was going to live that
02:24:56.480 long. I thought he was just going to live a few extra months. He comes back and he says,
02:25:00.400 I'm still alive. And there's a big newspaper article in the British newspapers about this
02:25:03.660 guy who rejects all. So after two years, he had an inoperable glioblastoma that now became
02:25:11.120 operable after metabolic therapy. So they debulked it. And now after another year, he doesn't have any
02:25:17.800 tumor left. And he never had radiation. He never had chemo. He had surgery very delayed.
02:25:23.680 And they did a histological analysis after the debulking, said, yes, you did have a GBM.
02:25:28.000 Because what a lot of people say, if you've lived that long, you never had a GBM.
02:25:31.680 That's bullshit. The problem is just that, I mean, you're creating a situation that leads to the demise
02:25:40.120 of those very people that you are trying to help. And when you irradiate the brain,
02:25:45.020 you free up massive amounts of glutamine by breaking the glutamine glutamate cycle. So those
02:25:50.480 tumor cells are sucking down massive amounts of glutamine. And then you give the steroids to
02:25:54.500 reduce the edema, which then elevates the blood sugar.
02:25:57.000 So I was going to give you two experiments, two dream experiments. So the second one would be
02:26:01.640 going back to sort of the more fundamental premise of this, which is what if resources were,
02:26:07.900 you know, no constraint, how could one unambiguously make the case slash test the hypothesis
02:26:16.080 that despite structural abnormalities in the mitochondria, the production of lactate and the
02:26:24.620 fermentation is not purely for respiratory compensation. In other words, we talked about
02:26:30.960 this idea that says you can have a structural deficit, but still be functionally good enough.
02:26:36.380 How can that hypothesis be tested? Because that seems to be one of the central arguments here.
02:26:43.120 Well, I mean, there's several ways we look at this. If a cell can live with ketones without
02:26:47.400 glucose and glutamine, you'd obviously have some mitochondrial function that would keep them alive
02:26:51.580 because they wouldn't be able to ferment.
02:26:53.100 But let's like, we're in a resource unconstrained world. So what are the dream experiments that would
02:26:57.860 test that in humans?
02:27:00.500 I mean, in vivo, because a lot of these mechanisms would be tested in vitro because you can't do those.
02:27:06.360 kinds of experiments. But the metabolic therapy that we have designed, Dom DiAgostino, myself,
02:27:13.580 Joe Maroon, who's the team surgeon for the Pittsburgh Steelers neurosurgeon, George Yu,
02:27:18.200 who is a prostate oncologist, prostate cancer oncologist. We all sat down and we built this
02:27:24.200 press pulse therapy. Okay. So if you deprive the tumor cells of their fermentable fuels
02:27:29.800 and you kill, and you essentially eliminate, I can't detect any more cancer in your body.
02:27:35.960 That's based on the biology of what the problem is. All right. So the dream experiments are to
02:27:42.700 ferret that out mechanistically in vitro. So to prove that this is the case, and we're doing that
02:27:47.220 right now when we target these things, these cells die. So you can put them in where normal cells
02:27:53.120 wouldn't die. So clearly what's going on here? I mean, it was shown in many papers. In fact,
02:27:58.460 back in the 30s and 40s, beautiful papers showing that the respiratory system of tumor cells is
02:28:03.520 massively compromised. Okay. If that's the case, then they're surviving on fermentation. There's no
02:28:08.940 other known biological system in the world that can provide alternative ATP.
02:28:15.200 But yet most people don't agree with that statement. So that's what I'm asking is what
02:28:18.540 experiment could take the debate out of that very important question?
02:28:22.160 Okay. So they don't believe it. If I look at the data and you look at the data and we both come
02:28:28.220 to the same conclusion, and this other guy looks at the same data and he says, I don't believe it.
02:28:32.420 Then it tells me the data are not convincing enough if everybody's acting in good faith.
02:28:36.300 Well, then you have to ask about what's good faith. If I have-
02:28:40.220 Or what's better data.
02:28:41.100 Okay. Look, here's the way I look at it. If science is a human activity, okay, there are people who say
02:28:47.840 things that are not true and everybody believes it. Right? Right? All right. So I look at something
02:28:53.280 and but I don't-
02:28:54.280 I'll refrain from making all political jokes right now.
02:28:57.540 Yeah, right. Right. I understand. But I understand completely. But the issue here,
02:29:02.320 of course, is that you have, it's one thing to say, okay, we had a review on a paper that we know
02:29:11.640 there's a massive biology on the role of cardiolipin in controlling the electron transport
02:29:15.340 chain. I mean, there's dozens and dozens of papers on this. And a molecular biologist,
02:29:19.260 I don't believe it. Well, what don't you believe? What part of this massive amount of scientific
02:29:25.060 evidence that you don't believe? I'm unfamiliar with cardiolipin, therefore it can't be right.
02:29:30.800 Well, that's not the reason to discount them. Right, right.
02:29:33.760 And when you write the paper up, why would you not cite Pete Peterson's massive compendium
02:29:38.600 of evidence saying mitochondria are abnormal? And you say mitochondria is normal. Well,
02:29:43.000 how does that jive with the massive amounts of evidence to say that's not-
02:29:48.520 What I try to do in all my writings, I never try to ignore an alternative fact to what I'm saying.
02:29:56.360 I try to say there is a fact that I'm not yet completely clear about, but I'm not going to
02:30:02.920 ignore it, okay? You'll find in the scientific literature today, in the top journals, that
02:30:08.620 they're ignoring massive evidence that don't support their position. And that's one of the
02:30:15.020 problems. And like, you know, we were saying that this problem in cancer, all these top journals
02:30:19.880 sell science nature. You know, 50% of them, up to 50% of the article can't be reproduced in
02:30:25.240 other people's labs. This is a crisis in the field. What's going on here? So you're ignoring
02:30:30.500 massive evidence that doesn't fit your particular mindset. So you will just discount it. I don't
02:30:37.100 think it's any different than the geocentric, heliocentric model of the solar system. The
02:30:42.500 Catholic Church refused to believe that the earth was not the center of the solar system,
02:30:47.160 despite all the evidence that said it was. They just refused to believe it. We have the exact same
02:30:52.320 thing in the cancer field. You have massive evidence showing that the mitochondria are
02:30:56.160 structurally and functionally dysfunctional. I don't want to believe it. What can you do about
02:31:03.500 that? What can you do about that when you have the evidence to show that and you choose not to,
02:31:08.480 you choose to ignore it? Is that any different than the heliocentric, geocentric system that we
02:31:12.860 had? The difference today is that we have 1,600 people.
02:31:16.180 Yeah, I mean, it's slightly different, right? But I don't want to get into the details.
02:31:19.100 It's a fact. You have fact. And don't forget, they didn't-
02:31:22.460 Well, but I think the Catholic Church was basically relying on a religious framework
02:31:28.160 as their counter-argument.
02:31:30.280 Of course.
02:31:30.720 And so their belief system was formed by something different. I think in the scientific-
02:31:35.760 Yeah, but when Galileo said, please look through the telescope to document that Copernicus was right,
02:31:40.900 they didn't want to look in the telescope. They didn't want to look in the telescope.
02:31:44.140 So because it would disrupt their worldview. If you've just put the list-
02:31:48.380 No, I mean, I think that's a fair statement. I guess, again, I come back to this through the lens
02:31:53.520 of I'd love to know what the experiments are that could- because I view it as a stalemate. If you're
02:31:59.120 looking at a body of literature and they're looking at a different body of literature and every time
02:32:02.160 everybody looks at everybody else's body of literature, they say, well, there's an alternative
02:32:06.680 explanation for this, then we're making no progress. The answer to me is collaborate,
02:32:12.200 generate new experiments where-
02:32:15.340 Well, that's why I think knowing the biology of the diseases as well as I think I do, and we never
02:32:20.600 can know completely everything because every human being is a different entity. You're dealing with
02:32:25.020 a different entity. If we can increase overall survival and improve quality of life, massively
02:32:31.720 advanced to what we're doing today, because we use the strategy based on what we understand to
02:32:37.820 be the biological problem and the results support that, then I think that's the advance. And
02:32:42.960 glioblastoma would be a wonderful-
02:32:45.220 So speaking of that, realistically, when do you think that case report of these four years
02:32:50.100 surviving cohorts will be published?
02:32:51.680 I'm going to try it. When I talk to him over there, I'd like to speak to the very physicians
02:32:54.880 that actually took the data from him, from Pablo.
02:32:58.360 How many patients are in that cohort?
02:32:59.860 Just him.
02:33:00.360 Oh, there's just one guy who survived four years.
02:33:02.400 Well, one guy because he rejected-
02:33:04.120 No, I understand. I misunderstood. I thought there were several patients.
02:33:06.720 Well, there's Andrew Scarborough who initiated a first couple of radiations and said, no more
02:33:10.860 of this. He took no radiation, no chemo. He's still going. He had a stage three astrocytoma,
02:33:16.340 which is also quite lethal. Then there's Alison Gannett. She's on the news. She has a website
02:33:21.320 saying that she survived GBM without this. I have other anecdotal reports based on what people
02:33:27.980 have told me. One poor guy, he had no money, no insurance, so they didn't want to rate it because
02:33:34.460 they wouldn't be able to rent any revenue from this guy. He just did ketogenic diets way back
02:33:39.960 before even I was talking about it. He's still alive 16 years.
02:33:43.120 But what was the, did they eventually do surgery on him?
02:33:48.760 They did surgery, but they didn't do anything else.
02:33:52.040 So what is it?
02:33:52.700 So again, these are anecdotal, but with Pablo, we have data. We have clear data from him.
02:33:57.460 So it's not like we don't have data from him. You know, we have a lot of things, a lot of these
02:34:02.900 things people would say, well, you can't do this. You can't do what I'm asking you to do because
02:34:07.740 it breaks the, it violates the standard of care. Okay. The standard of care should never have been
02:34:13.620 written in granite. It should be flexible. If you have something else that comes along that might be
02:34:18.020 better, you'd think there would be an enthusiasm. No, we have not seen that. We try to get this
02:34:23.640 through the University of Pittsburgh to try to do this. The advisory board, right? The IRB.
02:34:29.080 The IRB refused. Okay. So they would only, might consider metabolic therapy after standard of care
02:34:35.960 fail. Well, standard of care fails all the time. Why don't you try metabolic therapy as an
02:34:39.720 alternative to stay? Oh, no, we can't do that. Why? Well, because we can't do that. Why? Because
02:34:44.920 we can't do that. That means there's inflexibility. So we're up against firewalls after firewalls after
02:34:51.520 firewalls to try to change the way we continue. We're doing all the gene screening, mounting to
02:34:57.420 nothing because cancer is not a genetic disease. So we have all these firewalls that are preventing us
02:35:02.200 from moving forward the way I think we need to be moving forward. For a GBM patient, what do they
02:35:06.560 have to lose? There was a paper that just came out the other day and from out of British Columbia,
02:35:11.300 Canada, looking at, carefully looking at survival for GBM. They said it's woefully similar to the
02:35:16.800 1926 Bailey and Cushing paper for Christ's sake. I mean, what's going on here? You mean an 100,
02:35:21.540 almost 100 years? John McCain's size 12 months. That's no different than if he had the cancer,
02:35:26.240 than if he had the tumor in 1926. So that tells us we have a serious, serious problem and I'm
02:35:33.680 offering an alternative that might be able to change that. What is wrong with that? Why would
02:35:40.080 I be attacked for something like this? Right? So you tell me, I have to know what's going on here.
02:35:45.220 So I go up and I say, you can't irradiate the brain. Oh, you got to do it.
02:35:48.400 Here's my parting shot of advice, Tom, which is it's worth nothing, but your passion is palpable.
02:35:55.400 I lost a friend to GBM. So the very first person in my life that I ever knew that died of cancer
02:35:59.920 died of a GBM. And I was with him almost until the day he died. And it was the saddest thing to
02:36:05.720 see the last year of his, he lived 18 months and a year of it, he didn't, he couldn't see.
02:36:11.160 So, you know, talk about what is it like to be a 19 year old kid who can't see anything. And I look
02:36:18.160 at, uh, it's actually one of the saddest stories of, I don't even want to tell it. It's so upsetting.
02:36:21.660 Anyway, um, I get it. I think my advice would be the following, whatever you've been doing a,
02:36:28.000 the phone rings. What the hell? Perfect time. Um, whatever you've been doing is not getting
02:36:32.260 through. You got to do something different, right? So there's, there's a quote by someone who's
02:36:36.620 escaping me. It's like the definition of insanity is doing the same thing over and over again,
02:36:40.080 expecting a different outcome. You got to do something different. Well, I don't know what it
02:36:44.180 is. If I had that advice, I'd offer it, but, but I'm just saying you've got to try a new
02:36:48.060 approach to get that clinical trial done. Yeah. Well, you know, don't forget I'm a professor
02:36:52.060 at a, in an academic non-medical school environment, right? So we ferret, we, we design
02:36:57.120 the preclinical studies that allow the clinicians to then adapt it to their patient population.
02:37:03.460 So this is what there's very, we're the only, one of the only groups in the world that are actually
02:37:08.200 doing bench to bedside real research, because I have, I have tentacles for all these different
02:37:13.640 clinical things. It's, it's, I get it. All I'm saying is the current, you're, you're, you're
02:37:19.660 abutting a resistance and I, you've got to go around it. You've got to, you've got to find a
02:37:25.380 way to go around it. And it might be that you get enough of these case reports published that it
02:37:30.800 becomes very difficult to ignore. And people would say, look, you know, here's a concession.
02:37:35.640 We're going to do surgery immediately and then follow with metabolic therapy. Cause I think you're
02:37:41.120 going to have a very hard time saying no surgery, no corticosteroid, no radiation. I just don't,
02:37:47.040 I think that's metaphysically not going to work. No, no, no, no, I know. That was a judgment call
02:37:50.020 on the part of the, on the part of the clinician. But, but I'm saying if you're, if you're willing
02:37:53.580 to accept immediate surgery, but delaying or postponing radiation and or corticosteroid therapy
02:38:01.740 until they are necessary, either due to medical progression and or symptom control, uh, you have a
02:38:09.020 chance. And so of course the question then is you, you've got to find advocates on the other side of
02:38:13.900 this ledger, meaning, but the ledger meaning in terms of the thinking about this disease.
02:38:18.480 Yeah. Well, I agree with you. I mean, and so what would you suggest? What's the, what's the end
02:38:23.060 game? What's the roundabout approach? What you're, you're in the field. I mean, you're a great
02:38:28.580 discussion over that scotch that you promised me before we started this podcast.
02:38:32.720 See, see, so we're trying to, we're trying to do this, right? And we need guys like yourself and
02:38:40.240 others to get the word out that there are alternatives and that who's going to be the
02:38:44.420 bold one. And I know I'm speaking to now people who want to set up these special clinics, special
02:38:49.240 kind of treatment clinics where we can bring everything under the same roof. So you don't
02:38:53.180 have to run over this place in that place. We take the patients, this will happen. It will happen
02:38:57.760 because people want to live. Yeah. Look, I mean, that was going to be my, if, if, if forced to
02:39:02.400 give one idea now, cause I don't, I don't think I know the answer, but if I were going to give you
02:39:06.280 one suggestion, it would be do this from a position of pull, not push. So right now you are pushing
02:39:13.320 this idea. What you really want to do is take a page out of the Charlie foundation where they're
02:39:19.000 basically saying, look, in the end, the results were so dramatic that the parents of the children,
02:39:24.780 a third of whom now no longer suffer from epilepsy, another third of whom have at least a 50% reduction
02:39:31.320 in epilepsy. They basically become the voice of reason. And I think that's a part of the reason
02:39:36.500 today. Not the only reason I think the data are so good, but I think they're a part of the reason
02:39:40.840 why today the only place in sort of the traditional medical view where a ketogenic diet is viewed as a
02:39:48.340 legitimate first line therapy for, you know, recalcitrant disease is in epilepsy. Now I think
02:39:55.000 there'll be a day when that expands. So what I, what I, what I would hope is that there's a network
02:40:01.040 of people, family members, probably who have lost people would to GBM who would, would become the ones
02:40:08.480 that would be your mouthpiece, right? Would become the ones that would say, you know what? I'm tired of
02:40:12.840 the fact that my loved one died in nine months, seemingly in vain. And there's this, there's this
02:40:19.440 body of evidence, which look, admittedly at this point is small and is uncertain, but nothing in
02:40:24.500 science is certain, but they're offering an alternative. I want to know that that could be
02:40:29.040 tested. Yeah. And the thing that it kills me on these private foundations and things, their advisory
02:40:33.820 boards are made up of physicians that subscribe to the gene theory of cancer. So when the patients
02:40:39.060 and their advocates here, here's my second piece of advice. I know I said, I wasn't going to give
02:40:42.820 you any advice. My second piece of advice is you're fighting an uphill battle. You don't need
02:40:46.720 to, it, it could be a genetic disease and a metabolic disease simultaneously. I would argue
02:40:51.320 that cancer is when you think about the three diseases, the three disease processes that are
02:40:55.960 going to kill all of us sitting here right now in this room, it's going to be atherosclerotic
02:41:00.500 disease, neurodegenerative disease, or cancer. Statistically speaking, that's how we're going
02:41:05.880 to die of those three. I don't think there's any that are more evolved and complicated than
02:41:11.400 cancer. I think cancer is by far the hardest of those. And therefore, there's where I would
02:41:16.600 disagree. Well, but that's too long a discussion. The point is whether you agree with me or not,
02:41:21.320 let's argue the following, or let me state the following and or posit the following.
02:41:26.380 It's a very evolved condition. And therefore you could have genetic pressures, metabolic pressures,
02:41:33.560 immune pressures that all predispose to it. So I don't think it has to be an either or.
02:41:38.160 I think metabolic therapies could be valuable whether or not the genetic ideas of cancer are
02:41:43.320 right or wrong. So to me, it strikes me as an unnecessary fight, right? Instead, the answer
02:41:48.560 should be, look, we should have medical oncologists, radiation oncologists, surgical oncologists,
02:41:53.340 immuno-oncologists, and metabolic oncologists, period. Now you might argue those radiation oncologists
02:41:59.120 are causing more harm than good. That's beyond my pay grade. You might be right. But you're basically
02:42:04.120 arguing for a fifth branch of oncology, which is the medical oncologist above the three that we
02:42:09.760 conventionally have. I think the immuno-oncologist is coming into his or her own right now. I don't
02:42:15.020 think it's worth arguing about whether it's a genetic disease or metabolic disease. It's just
02:42:18.360 a goddamn hard disease. And we need every therapy imaginable. And sometimes that will be doing things
02:42:24.100 that are completely new as you've proposed. So anyway, on that note, I want to thank you very much
02:42:30.520 for your generosity of time and just your passion for this and sort of how tirelessly you've worked
02:42:36.800 on this. I mean, this is only our first time meeting today, Tom, but I've been familiar with
02:42:40.720 your work for probably eight years now, which is a small fraction of the amount of time you've put
02:42:45.460 into this. Dom is a very close friend. And so through Dom and through Bob, I've learned a lot more
02:42:50.860 about your work. And I know that a lot of people listening to this are going to be rooting for you
02:42:54.860 to do this. Is there anything that someone who's listening to this, who's got a loved one who's
02:43:01.840 either died of GBM or has GBM, that they can do to increase the chances that either others can get
02:43:10.360 the types of therapies you're talking about in clinical trials or that their loved ones themselves
02:43:15.240 can? What else can they do? Well, I mean, in my position as a researcher who does the preclinical
02:43:20.800 studies, I mean, we get support from Travis Foundation, you know, the Metabolic Therapy
02:43:25.540 Foundation. And that's what keeps our program going. And that's what tells us what we think
02:43:31.780 should work really well or what might not work to help these people get the outcome that they want,
02:43:37.880 which is high quality of life and living a lot longer. So my big thing is that. In other words,
02:43:45.400 we can identify those. And where do you do that? You need funds for that. And the federal
02:43:50.060 government is mostly like what gene is involved. So this is where it comes back to the same problem
02:43:54.540 again. You don't get funding for things that actually can really work versus studying the
02:43:59.440 disease. Let's look at the meta. Let's study the disease more. We don't need that. We know we have
02:44:03.500 a path. We have a clear path. So is there an easy path for patients who want to make financial
02:44:08.220 contributions to the lab? Is it through a foundation that is the easiest? Yeah, well, there's two ways to do
02:44:12.120 it. You can either do it through the foundation because we have a continual grant set up through
02:44:16.180 single cause, single cure foundation. Okay. So we'll link to that to make sure that people know
02:44:20.600 what that is. And also at Boston College, if you want to fund the work directly through the
02:44:25.020 university, it has to be through a very specific statement. Otherwise, the university will absorb
02:44:31.280 some of the other funds. So basically, that's the way. Now, what we do then is our data are immediately
02:44:38.220 given to the clinical people who then put it on their patients and then feed me back and say,
02:44:43.720 this is working well, or we don't think this is doing as well as we should. Why don't you tweak
02:44:47.640 it in this direction? So I work with the physicians directly and I give them the preclinical information.
02:44:53.520 They feed me back and see how it's working. Sometimes it works a hell of a lot better in
02:44:57.040 the human than the mouse. So let's be sure that we have from you any and all means that people who
02:45:02.720 are passionate about this, interested in this, either personally or through sort of indirect
02:45:07.200 experience can support this work. And more importantly, I think, create maybe a bit of a groundswell
02:45:13.360 that puts a little bit of pressure on the IRBs to say, look, this is, you know, GBM is as high
02:45:19.160 stakes as it gets, right? It's the type of cancer that gives cancer a bad name. And maybe this is
02:45:24.800 one area where we have to increase our appetite for risk in clinical trials.
02:45:29.920 I agree with that. And I think that this is a disease that we think we can make major advances
02:45:34.580 in and why not want to give it a shot? Because it's not going to hurt anybody. It's not going to
02:45:39.200 accelerate their demise. It's only going to-
02:45:41.100 Well, I mean, I would disagree with that only in terms of a talking point to say it could.
02:45:45.000 We don't know. But that's the point of risk, right? I mean, when the outcome is so asymmetrically
02:45:50.920 bad, which is uniform death in an accelerated fashion, we have to be willing to take the risk
02:45:58.260 of potentially doing worse than that. I don't think that's the case.
02:46:01.460 I've never seen it.
02:46:02.280 I understood. But I think the way we talk about this, when we talk about this as though
02:46:06.960 there's no risk, I think that reduces our credibility with people who say, well,
02:46:12.220 how can you say that?
02:46:12.960 Well, any open cranial surgery produces risk.
02:46:16.520 Yeah, that's the point.
02:46:17.560 And that's going to be a part of all what we're doing.
02:46:20.520 Well, the point is, you know, Bob's heard me rail on this many a time. This sort of idiotic
02:46:26.680 idea of a Hippocratic oath, which is technically he didn't even say it and it's such a dumb thing
02:46:30.520 anyway. First, do no harm. I mean, you couldn't do any good if you weren't at least willing
02:46:34.420 to do some harm. No one goes into it wanting to do harm. But anyway, this has been really
02:46:40.140 exciting and I really appreciate your time and your insights and above all else, the work
02:46:44.760 you've done. So thank you, Tom.
02:46:45.860 Yeah, thank you.
02:46:48.720 You can find all of this information and more at peteratiamd.com forward slash podcast.
02:46:53.980 There you'll find the show notes, readings and links related to this episode. You can also
02:46:58.800 find my blog and the nerd safari at peteratiamd.com. What's a nerd safari, you ask? Just click on
02:47:04.980 the link at the top of the site to learn more. Maybe the simplest thing to do is to sign up
02:47:08.780 for my subjectively non-lame once a week email where I'll update you on what I've been up
02:47:13.040 to, the most interesting papers I've read, and all things related to longevity, science,
02:47:17.800 performance, sleep, etc. On social, you can find me on Twitter, Instagram, and Facebook,
02:47:22.960 all with the ID peteratiamd. But usually Twitter is the best way to reach me to share
02:47:27.380 your questions and comments. Now for the obligatory disclaimer, this podcast is for general informational
02:47:32.440 purposes only and does not constitute the practice of medicine, nursing, or other professional
02:47:37.000 healthcare services, including the giving of medical advice. And note, no doctor-patient
02:47:42.220 relationship is formed. The use of this information and the materials linked to the podcast is at
02:47:47.520 the user's own risk. The content of this podcast is not intended to be a substitute for professional
02:47:52.200 medical advice, diagnoses, or treatment. Users should not disregard or delay in obtaining
02:47:57.300 medical advice for any medical condition they have and should seek the assistance of their
02:48:01.560 healthcare professionals for any such conditions. Lastly, and perhaps most importantly, I take
02:48:07.060 conflicts of interest very seriously. For all of my disclosures, the companies I invest in and
02:48:11.900 or advise, please visit peteratiamd.com forward slash about.